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A variety of sampling methods are used in quantitative studies of myelinated sural nerye
fibres, however there is no consensus as to which method is most accurate. This study
compares whole fascicular sampling and systematic sampling of myelinated fibres with
evaluation of the total myelinated nerve {ibre population.
Two control and eighteen pathological sural nerves showing varying degrees of
demyelination/remyelination and axonal degeneration were examined. The fascicular area,
number of myelinated fibres, myelinated fibre density, fibre diameter and axonal diameter
rù/ere measured in each fascicle of all the nerves using I micron plastic cross sections stained
with osmium tetroxide. Each fascicle was divided into measuring frames, and the number
and size of myelinated fibres in each frame (field) counted using the Quantimet 500MC
computer-assisted image analysis system (Leica-Cambridge, UK). Frequency distributions
of myelinated fibre density and size were calculated. The mean values and frequency
distributions of fibre density, fibre diameter and axonal diameter of each sample were
compared to the whole population by the Wilcoxon Rank-Sum test and Kolmogorov-
Smirnov goodness-oÊfit test.
Fascicular sampling of the two control sural nerves (14 fascicles) showed that 8 fascicles
had different myelinated fibre density (P<0.05), and 8 fascicles had different fibre diameter
and/or axonal diameter (P<0.05) when compared to the whole population. In the 18
pathological nerves there were 168 fascicles. When compared to the whole population, 61
fascicles had different myelinated fibre density (P<0,05), and 90 fascicles had different fibre
diameter and/or axonal diameter (P<0.05). There was no relationship between the
myelinated fibre density of each fascicle and the fascicle diameter or area in either control
and pathological sural nerves.
It is concluded that morphometric study of myelinated fibres of one or part of a fascicle
cannot accurately represent the whole myelinated fibre population in the sural nerve.
Systematic sampling of one third to half of the total transverse fascicular area in control and
pathological sural nerves did not accurately depict the fibre diameter or axonal diameter of
the whole myelinated fibre population. The myelinated fibre density derived from
systematic sampling was more accurate than that derived from fascicular sampling. The
spatial distribution of the number and size of myelinated fibres within and between fascicles
is heterogeneous in the sural nerve. It is necessary to quantitate more than half the area of
every fascicle to acquire accurate data about myelinated fibres that is representative of the
whole myelinated fibre population.
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Pathological studies of peripheral nerves are used widely in the investigation of peripheral
nerve disorders (Dyck and Lofgren 1968, Dyck et al. 1993, Dyck et al. 1996, Thomas
l97}a, Thomas et al. 1997), and other neurological diseases (King 1994). Quantitative
studies of nerve fibre morphology are used to supplement the information obtained by
qualitative histological assessment (Dyck et al. 1993). Morphometric studies are
particularly useful in assessment of the myelinated nerve fibre population, aiding in the
recognition of loss or alterations in size (atrophy or enlargement) of myelinated fibres (Dyck
et at. 1993, Thomas et al. 1993). Pathological studies are usually undertaken on sural
nerve, and occasionally on radial, anterior tibial, or superficial peroneal nerve biopsies.
More morphometric data is available for the sural nerve than for any other nerye (Behse
1990, Dyck et al. 1993, Friede and Beuche 1985a, Ferriere et al. 1985, Jacobs and Love
1985, O'sullivan and Swallow 1968, Thomas et al. 1993, Tohgi et al. 7977b).
The following discourse is a review of the basic anatomical features of peripheral neryes,
and of quantitation of myelinated fibres in transverse sections of peripheral nerve, with
special emphasis on the sural nerve.
2.2 ANATOMY OF PERIPHERAL NERVES
The peripheral nerves consist of nerve fibres, supporting cells, blood vessels and
collagenous connective tissue, all enclosed within continuous connective tissue sheaths
(Thomas et al. 1992,7993,1997).
5
2.2.1 NERVE FIBRES
i) Myelinated and Unmyelinated Fibres
Nerve fibres are usually categorized as myelinated and unmyelinated nerve fìbres according
to their relationship to Schwann cells (King et al. 1994, Ross et al. 1995, Thomas et al.
1992, Thomas et al. 1993, Thomas et al. L997). Myelinated axons lie singly within a chain
of Schwann cells, each of which contributes to the myelin sheath around the axon.
Unmyelinated nerve fibres consist of one or more axons invaginated in a Schwann cell
Myelinated fibres (MF)
Normal myelinated nerve fibres raîge in size from l-221tm in the adult and comprise 20%-
25Yo of all nerye fibres. The thickness of myelin varies according to the fibre type and in the
sural nerve range from 0.2-6.0pm. Myelinated fibres first appear in the fetal sural nerve at
21 weeks with numbers increasing to 25,000MF/mm2 at 36 weeks (Shield et al. 1986).
In transverse section, a myelinated fibre shows two main concentric zones: an outer
Schwann cell zone and an inner axon zone. The Schwann cell zone consists of three parts:
the outer (abaxonal) and inner (adaxonal) cytoplasmic compartments and between them the
myelin compartment (Thomas et al. 1993). The myelin compartment is usually used as a
marker for recognition and quantitation of myelinated fibres. Most researchers agree that
myelinated fibres are near cylindrical (Dyck et al. 1993, Thomas et al. 1993, Thomas et al.
1997). The transverse contour of myelinated axons is boomerang in shape in the region of
Schwann cell nuclei, crenated in the paranode, and circular or near circular in the region
between paranode and Schwann cell nucleus region (Karnes et al. 1977).
In longitudinal sections and teased fibres, the myelin sheath is segmented as each Schwann
cell wraps only a short segment of axon. The junction where two adjacent Schwann cells
meet is devoid of myelin sheath, and only covered by basal lamina. This site is called the
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node of Ranvier (1875). The segments ensheathed by myelin are the internodes. The
region adjacent to the node of Ranvier is called a paranode. A node of Ranvier and its two
bordering paranodes constitute a Paranode-Node-Paranode (PNP) region.
Myelin sheath
The structure of the myelín sheath
On electron microscopy, the myelin sheath surrounding the axon is composed of multiple
layers of Schwann cell membrane wrapped concentrically around the axon. During
development, the process of myelination is initiated by an increase in the length of the
mes¿rxon connecting the periaxonal space to the surface of the Schwann cell. The thin layer
of c¡oplasm between the pairs of membranes is extruded to produce the radially repeating
structure of alternate dense and less dense lines characteristic of myelin in electron
micrographs (Thomas et al. 1997). The dense lines are derived from the cytoplasmic aspect
of each pair of membranes, and the less dense lines from the apposed outer surface of each
pair of membranes. There is a small extracellular space separating the less dense line which
appears as an intervening lucent gap in electron micrographs.
The thichtess of the myelin sheath
The thickness of the myelin sheath is related to both the axonal diameter and the length of
the internode. Larger myelinated fibres usually have a thicker myelin sheath (Beuche and
Friede 1985, Thomas et al. 1993, Thomas et al. 1997).
S chmi dt-Lantermqn c I eft s
Myelin is interrupted at intervals by the presence of oblique clefts at an angle of about 90 to
the long axis of the sheath termed the Schmidt-Lanterman clefts (Hall and Williams 1970).
The Schmidt-Lanterman clefts provide a pathway for protoplasmic connections between the
inner and outer compartments of the Schwann cell. The pathway may be the route by which
metabolic materials pass between these two parts of the Schwann cell, and onwards to the
axon (Ghabriel and Allt 1981, Hall and Williams 1971, K¡ishnan and Singer 1973, Mugnaini
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et al. 1977). The Schmidt-Lanterman clefts may be involved in the longitudinal growth and
metabolic maintenance of myelin (Celio 1976, Thomas et al. 1993). The clefts probably
provide elasticity in the myelin sheaths, so that the internodes are able to elongate (Friede
and Samorajski 1969). The number of Schmidt-Lanterman clefts increases with increasing
fibre diameter and thickness of the myelin sheath. The number of Schmidt-Lanterman clefts
is greater in regenerating and remyelinating fibres than in normal fibres (Behse et al. 1990,
Buchthal et al. 1987, Friede and Samorajski 1967, Hiscoe 1947, Thomas et al. 1993,
Thomas et al. 1997).
Biochemistry of myelin
Lipids and proteins are the two principal components of the myelin (Mezei 1993, Thomas e/
al. 1997). Sphingomyelin, cerebroside and sulfatide are the main components of myelin
lipids in both central and peripheral nervous system (PNS) Peripheral nerve myelin
contains a larger proportion of sphingomyelin and less cerebroside and sulfatide than central
nerve myelin. In some animals the ganglioside LMl (sialosyllactoneotetraosylceramide) is a
characteristic component of myelin in the PNS (Mezei 1993, Thomas et al. 1997). The
major components of myelin proteins in PNS are P6, myelin basic proteins (MBPs),
peripheral myelin protein 22 (Pl\/P22), and myelin-associated glycoprotein (MAG). Po is an
integral membrane protein of the myelin sheath of 28KD, which contributes 50% of the
total myelin protein and consists of an extracellular immunoglobulin-like domain, a single
transmembrane domain and an intracellular cytoplasmic domain. Ps protein plays an
important role in myelin compaction and stabilizing the major dense line of the myelin (Ding
and Brunden 1994, D'IJrso et ql. 1990, Lemke and Axel 1985, Mezei 1987, Poduslo 1946).
MBPs are a series of highly charged molecules of l2-20KD, located in the major dense line
and account fof 15-20Yo of the protein content of PNS myelin (Greenfield et al. 1982).
Pl\/P22 is a22I{D protein that is localized to compact myelin, and contributes 2-5%o of PNS
myelin protein. Pl\/P22 is membrane associated and has a complex structure consisting of
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four transmembrane domains, two extracellular loops, one intracellular loop and two short
intracellular tails (Pareek et al. 1993, Thomas et al. 1997). MAG comprises approximately
0.1% of the total myelin proteins in the PNS, and is localized to the external and periaxonal
layers of the myelin sheath, and non-compact myelin at the Schmidt-Lanterman clefts and
paranodal terminal loop (Brady and Quarles 1988, Lai et al. 1987, Martini 1994). Two
major functions have been postulated for MAG: maintenance of the structural integrity of
periaxonal regions of the myelin sheath, particularly the 12 to 14nm Schwann cell-
cytoplasmic periaxonal collar, and mediation of intercellular interactions (Martini and
Schachner 1988, Trapp 1988, Trapp et al. 1984).
fnternodes
Each internode consists of three main parts: a central stereotyped internodal (STIN) region
and two paranodal regions. The paranodal regions of an internode are dilated, the distal
one slightly more so than the proximal one, forming the paranodal bulbs. The length of the
node of Ranvier is approximately l¡rm. The internodal length ranges from 200pm to
1500¡rm. The STIN forms about 95Yo of the whole internodal length, and each of the
paranodal regions form about 2-3Yo of the whole internodal length. The length of internode
is related to axon diameter (Behse 1990, Friede et al. 1981, Thomas et al. 1993, Thomas e/
al. 1997, Williams and Kashef 1968, Williams and Wendell-Smith 1971).
Myelinated fibre âxons
The axon consists of a relatively firm gelatinous cord of neuronal cytoplasm, enclosed by
the axolemma. The axon is separated from the adaxonal Schwann cell membrane by a
narrow extracellular gap, the periaxonal space or the adaxonal space (Thomas et al. 1993,
'Waxman 1985). The axoplasm consists of a fluid cytosol and formed elements. The
formed elements consist of neurofilaments, microtubules (neurotubules), mitochondria,
axoplasmic (endoplasmic) reticulum, dense bodies, multivesicular bodies, membranous
cisterns and tubes, membranous bound vesicles, the cytoskeleton, and granular material.
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Formed elements are most numerous and elaborate in the peranodal regions. The size of
the axon is by conventiona measured in the STIN region and ranges of 1 to 20¡tm diameter
in mammalian peripheral nerves. fn normal human sural nerve, the myelinated axon
diameter is usually less than l2¡tm (Bardosi et al. 1987, Friede and Beuche 1985a). The
axon is smaller in the paranodal region than in the STIN region (Thomas et al. 1993,
Thomas et al. 1997).
Unmyelinated fibres (UFs)
Unmyelinated axons are also enveloped by Schwann cells. One or more unmyelinated
axons may be enclosed by a single invagination of the Schwann cell surface membrane
(Thomas et al. 1993). Due to the small size, IIFs are better studied by electron microscopy.
In human sural nerves, the daimeter of unmyelinated axons ranges from 0.2 to 3.5pm with a
unimodal frequency distribution of frbre diameter (Aguayo et al. I97L, Dyck and Lambert
1969, Dyck et al. T97Lc, Jacobs and Love 1985, Ochoa and Mair 1969a, Ochoa and Mair
1969b, Weller 1967).
Schwann cell-axon relationships
All axons are enclosed by Schwann cells. As discussed in sections 2.6.7 and 2.6.8 (see
pp37-40) the thickness of myelin sheaths and the number of myelin lamellae are linearly
related to the axonal diameter (Behse 1990, Ferriere et al. 1985, Friede and Beuche 1985a,
Friede and Beuche 1985b, Schroder et ql. 1973). Close reciprocal relationships exist
between Schwann cells and axons. Both send signals and trophic substances to promote
mutual growth, survival and differentiation (Mezei 1993).
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Axonal regulation of Schwann cell
Axonal factors regulate Schwann cell proliferation. During maturation and in adult life, all
Schwann cells are related to axons in normal nerves (Aguayo et al. 1976). Schwann cells
without axons are rarely found. Axons are mitogenic for Schwann cells in tissue culture
(Wood and Bunge lg75), and axonal degeneration, demyelination and axonal regenerating
sprouts can stimulate the proliferation of Schwann cells (Griffin et al. 1990, Pellegrino and
Spencer 1985). Axonal contact is necessary for survival of Schwann cells. Schwann cells
cannot survive after the axons are lost, and will atrophy and gradually disappear (Roytta and
Salonen 1988, Thomas 1948, Weinberg and Spencer 1978). Some properties of axons,
such as axonal diameter and specific axolemmal molecules, act as signals to stimulate
myelination in development and axonal regeneration (Grifün et al. 7993, Yoyvodic et al.
1989, Weinberg and Spencer Lg76). After Schwann cells lose contact with axons, delayed
re-contact with axons can result in Schwann cells that are less able to respond to axonal
signals to form myelin (Li et al. 1997). Axonal contact is necessary for the Schwann cells to
synthesize basal lamina (Bunge et al. 1980,1982). The maintenance of the myelin sheath is
influenced by the axon (Griffrn et al. 1993), and the volume of the myelin is regulated by the
axonal diameter and the internodal length (Friede and Bischhausen 7982, Smith et ol. 1982).
Schwann cell influence on axons
Schwann cells exert a profound influence on axons. Close intercellular contact between
myelinating Schwann cells and axons is necessary for maintaining axon size and function.
Segmental demyelination of myelinated fibres may decrease local neurofilament
phosphorylation, axonal diameter and axonal transport, and increase local neurofilament
density (Dewaegh et al. 1992).
After nerve transection, Schwann cells commence synthesis of nerve growth factor Cit{GF)
and nerve growth factor receptor (ITGF-R) (Heumann et al. 1987, Johnson et ql' 1988,
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Taruuchi et al. 1988). Schwann cells undergo a series of mitoses and begin to divide
(Clemence et ql. 1989, Pellegrino et al. 1986, Pellegrino and Spencer 1985). The
proliferating Schwann cells and the regenerating axonal sprouts enclosed by the old basal
lamella form the Bands of Büngner through which axons regenerate and extend distally.
The old basal lamina is very slowly broken down into fragments (Grifün et al. 1993), and
during this period axons regenerate and induce the Schwann cell to form new basal lamina.
Cell adhesion molecules (CAMs) in axon-Schwann cell interactions
The intimate relationships between axons and Schwann cells are mediated by specific
proteins, termed cell adhesion molecules (CAMs) (Grifün et al. 1993, Salzer 1995). These
proteins are located on the apposed plasma membranes of the periaxonal space or in the
extracellualr matrix (Burgoon et al. 1991, Martini and Schachner 1986, Mirsþ et al. 1986,
Trapp et al. 1989, Trapp and Quarles 1982). Abnormal CAMs can disrupt the structure of
periaxonal space (Yu and Bunge 1975) and interfere with axon ensheathment, nerve fibre
growth, and Schwann cell proliferation and differentiation (DeWaegh et al. L992, Einheber
et al. 1993, Letourneau et al. 1990, Letourneau et al. 1991, Marchionni et al. 1993, Sadoul
et al. 1990, Sobue and Pleasure 1985). CAMs may be divided into three major families
(Salzer 1995): (1) A family of proteins showing significant sequence and structural
homology to the immunoglobulins, termed the immunoglobulin gene superfamily (Ig-CAM)
(Salzer and Colman 1989, Williams and Barclay 1988); (2) L family of calcium-dependent
adhesion molecules, the cadherins (Takeichi 1991); (3) A family of heterodimeric receptors,
the integrins (Albelda and Buck 1990, Hynes 1992, Reichardt and Tomaselli 1991). Usually
representative proteins of the three families are present in a single cell simultaneously
(Rutishauser and Jessell 1988) and these are involved in the interactions between cells.
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ii) Classification of Peripheral Nerve Fibres According to Their Diameter, Function
and Conduction VelocitY
According to diameter, peripheral nerve fibres can be divided into three groups: d B and C
(Boyd and Davey 1968, Ochoa 1976, Thomas et al. 1997, Weller and Cervós-Navarro
1e78).
Group A
Nerve fibres in group A range from 1-20¡rm in diameter and include somatic afferent and
efferent myelinated fibres. Group A fibres can be subdivided according to their size and
function into afferent groups, I, II and III, and efferent groups, oc, B and y. In the adult cat
Group I fibres range from 10 to 20¡rm in diameter, have a conduction velocity of 50-100m/s
and carry impulses from muscle spindles and tendon organs. Group II fibres ruîge from 5-
l5pm with conduction velocities of 2}-70m/s and carry impulses from secondary sensory
endings on the intrafusal muscle fibres within muscle spindles and cutaneous sensory fibres.
Group III fibres range from 1-7¡rm in diameter, with conduction velocities of 5-30m/s, and
include the fibres responsible for nociception and some aspects of cutaneous sensibility'
The efferent ø-fibres (diameter 9-20¡tm, conduction velocity 50-100m/s) are exclusively
skeletomotor; the B-fibres (diameter 9-l5pm, conduction velocity 50-85m/s) are both
skeletomotor and fusimotor; and the y-fibres (diameter 4.5-8.5¡rm, Òonduction velocity 20-
40m/s) are exclusively fusimotor.
Group B
Nerve fibres in group B are generally less than 3pm in diameter and include myelinated
preganglionic fibres of the autonomic nervous system which conduct impulses at 3-l5m/s.
Group C
Fibres in group C have a range of 0.2-1.5¡rm in diameter and include postganglionic
autonomic efferent frbres which conduct impulses at 0.3-1.6mls.
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2.2.2 CONNECTIVE TISSUES
The connective tissue components of a peripheral nerve can be divided into three parts:
endoneurium, perineurium and epineurium (Ross et al. l991,Thomas et ol' 7992, Thomas ¿l
al. 1993, Thomas et al. 1997).
Endoneurium
The endoneurium is mainly composed of collagen fibrils and fibroblasts. The interstices
between the fibres of peripheral nerves aÍe packed with collagen fibrils in a
mucopolysaccharide ground substance. The collagen fibrils connect the nerve fibres to form
fibre bundles. Most of the fibrils run longitudinally in parallel with nerve fibres, and have
relatively uniform diameter in the range 30-65nm. Fibroblasts are the principle cellular
constituents of the endoneurium. On cross section, fibroblasts lie free between the
endoneurial collagen. They are believed to be responsible for the production of the major
part of the extracellular endoneurial connective tissue. Sometimes, a few mast cells and
macrophages are also found in the endoneurium in control nerves. They are related to the
immune system of the peripheral nervous system (Thomas et al. 1993,1.997).
Perineurium
The perineurium is the concentric connective tissue which surrounds the endoneurium and
its contained nerve fibres to form nerve fascicles. Perineurium consists of layers of sheets of
extremely flattened, squamous-like cells, inter-leaved by thin layers of fine collagen fibrils
aligned parallel to the axis of the nerve, and serves as a semipermeable barrier. The
collagen fibrils range from 40-80nm in diameter. Occasionally, elastic fibrils are present in
the perineurium, and fibroblasts and mast cells are found in the outer layers. The thickness
of the perineurium is related to the diameter of the contained nerve fascicle (Gamble and
Eames 1964, Ross et al. 1995, Thomas 1963, Thomas and Jones 1967, Thomas et al. 1993,
Thomas et al. 1997, Tohgi et al. 1977b).
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Epineurium
The epineurium is the outermost layer of the peripheral nerve sheath, consisting of massed
collagen fibrils with a longitudinal or shallow spiral orientation, interspersed with occasional
elastic fibres, fibroblasts, mast cells, and the small arteries veins which supply and drain the
endoneurial capillary plexus. The collagen fibrils in the epineurium bind the fascicles
together and are larger than those in the endoneurium and perineurium, and tange from 60
to 100nm in diameter. The epineurium can be divided into two parts: the outer layers of the
epineurium (epifascicular epineurium) which form the outermost tissue of the nerve trunk,
and the inner layers (interfascicular epineurium) which extend between the fascicles. The
epineurium has a protective function in cushioning the fascicles against damage by
compression (Ross et al. 1995, Thomas et al. 1993, Thomas et al. 1997).
2.2.3 VASCULATURE OF PERIPHERAL NERVES
Small arteries and veins ramify and branch in the epineurium. The arteries penetrate the
perineurium at an oblique angle, then divide into capillaries to supply the endoneurial
capillary plexus (Ross et al. L995, Thomas et al. 1992, Thomas et al. 1993).
2.3 PATHOLOGICAL ANATOMY OF PERIPHERAL NERVES
Disorders of the peripheral nervous system can also be classified into those that primarily
affect nerve fibres, and those that primarily affect connective tissues or blood vessels with
secondary effects on the nerve fibres (Dyck et al. 1993, Thomas et al. 1997). According to
the location of damage, peripheral neuropathies can be divided in to neuronopathies,
axonopathies, and demyelinating neuropathies (Dyck et al. 1993, Ki.tg et al. 1994, Ross e/
al. 1995, Thomas et al. 1997).
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2.3. 1 DEMYELINATING NEUROPATHMS
Segmental Demyelination
Demyelination in peripheral nerves usually displays segmental loss of myelin sheaths. Loss
of myelin may be limited to the region of paranode (paranodal segmental demyelination) or
of internode (internodal segmental demyelination) (Dyck et al. 1993). The mechanism of
demyelination varies, depending on the disease process, and can be divided into primary and
secondary types of demyelination (Dyck et ot. 1993, King 1994, Thomas et al' 1992,
Thomas et al. 1997).
P rimary s e gm ent al de my e li nati on
Primary segmental demyelination is caused by abnormalities affecting the Schwann cells or
the myelin. The axon is relatively normal. Demyelination of this type affects internodes on
a random basis (Dyck et al. 1993, King et al. 1994. Thomas et al. 1992, Thomas et ol'
lg97). The mechanism of demyelination varies according to the disease process. In the
Guillain-Barré syndrome, myelin is actively stripped off axons by macrophages, whereas in
experimental lysolecithin demyelination there is detergent related dissolution of myelin
(carpenter l972,Lampert 1969, Prineas 1972, Wisniewski et al. 1969).
S e c ondary s e gm ental demye linati on
This type of demyelination is secondary to pathological change involving the axon (Dyck et
al. 1993,Kinget al. 1994, Esiri 1995, Thomas et al. 1997). In secondary demyelination,
individual fibres may have multiple consecutive internodes affected (clustered
demyelination) while neighbouring frbres remain unaffected (Dyck et al. 1993, Esiri 1995,
King 1994, Thomas et at. 199.} Thomas et at. 1997). Secondary demyelination was first
recognized in studies of uraemic neuropathy (Dyck et al. 1971a, Thomas et al' l97I).
Secondary demyelination may be due to axonal atrophy as shown in the animal model of
permanent axotomy (Dyck et al. l98Ia, Dyck et al. 1985). Enlargement of the axon can
also cause secondary demyelination, such as in giant axonal neuropathy (Spencer and
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Schaumburg 1977) and polyglucosan neuropathy (Yoshikawa et al. 1990). In some
neuropathies, secondary demyelination is probably induced by axonal degeneration without
obvious change of axonal caliber @ngelstad et al. 1997, Gabreëls-Festen et al. 1992,
Llewelyn et al. 1991). In human neuropathies, the secondary type of segmental
demyelination is more common than the primary type (Dyck et al. 1993).
Features that both primary and secondary demyelination have in conunon include (1)
paranodal or internodal demyelination, (2) remyelination, (3) small myelin breakdown
products, (4) intact axons, and (5) normal ultrastructural features of axons. In secondary
demyelination: (1) the axons are smaller or larger than they should be considering myelin
thickness, (2) demyelination and remyelination affects especially fibres showing severe
axonal attenuation, and (3) demyelination and remyelination are clustered on individual
fibres and not randomly distributed (Dyck et al. 1993, Thomas et al. 1997).
2.3.2 REMYELINATION
After demyelination, the Schwann cells divide and surround the denuded axon to form new
myelin. The destroyed myelin sheaths are replaced by myelin supplied by two or more
Schwann cells, rather than a single one as originally. Therefore, the resultant remyelinated
segments are of varying length, but all usually shorter than the original unless only
paranodal widening has occurred (Esiri 1995, King 1994, Thomas et al. 1992, Thomas et
al. 1997). The remyelinating myelin sheath will be initially disproportionately thin
compared with the relatively normal axonal calibre. Repeated attempts at remyelination in
chronic demyelinating diseases eventually result in Schwann cell hyperplasia and the
formation of concentric Schwann cell processes known as 'onion bulbs'. The affected nerve
becomes enlarged or hypertrophic as a result (Dyck et al. 1993, Esiri 1995, King 1994,
Thomas et al. 1992, Thomas et al. 1997).
t'7
2.3.3 AXONAL DEGENERATION
The primary pathological change is axonal damage. It can be divided into the following
subgroups (Dyck et al. 1993, Thomas et al. 1997).
Wallerian degeneration
An axon cut off from its parent cell body undergoes Wallerian degeneration. The distal
axon develops irregular swellings and break into fragments which eventually become
absorbed. The myelin sheath around the axon is destroyed and digested.
' Dying-back' axonopathy
The axonal damage is manifest first and most severely at the distal ends, and degeneration
typically progresses in a distal-proximal direction.
Axonal sequestration
During a slowly evolving axonal degeneration, prominent axon-schwann cell networks
develop. These are related to the ingrowth of processes from adaxonal Schwann cell which
branch and enclose multiple small compartments of the axon.
2.3.4 AXONAL ATROPHY, MYELTN REMODELLTNG, AND SECONDARY
DEMYELINATION
Axonal atrophy
Axonal atrophy is usually due to chronic neuronal injury (Dyck et al. 1993, Thomas et al.
1992), and has been identified in uraemic neuropathy (Dyck et al. I97Ia, Thomas 1,977),
and Friedreich's ataxia (Dyck et al. 1971b). In Friedreich's ataxia progressive axonal
atrophy may lead to axonal degeneration which occasionally can be demonstrated in sural
nerve biopsies and appears to be a final event in this type of axonal atrophy (Dyck et al.
1971b). After axon section, the proximal axon retracts, and the axonal diameter decreases
(atrophies) over the course of the ensuing 3 months. If satisfactory regeneration takes
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place, the axonal diameter recovers; if regeneration does not occur, axonal atrophy
progresses, and demyelination associated with such axonal atrophy occurs later (Aitken and
Thomas 1962, Cragg and Thomas 1961, Dyck et al. I98la, Dyck et al. 1985). Therefore,
axonal atrophy may result in eventual axonal degeneration, and disappearance of the axon.
Myelin remodelling
The length of internodes remain relatively unchanged in healthy adults. When an ¿Ìxon
atrophies, a type of myelin remodelling occurs, in which the myelin spiral length becomes
smaller than it was, and the length of internodes increases (Dyck et al. l98la).
Secondary demyelination due to axonal atrophy
Segmental demyelination is commonly associated with axonal loss (Dyck et al. 1977a, Dyck
et al. I977b, Hopkins 1970, Thomas et al. l97l). Dyck and co-workers (1971a, 1971b)
found that in uraemic neuropathy and Friedreich's ataxia, which are thought to be primary
neuronopathies, (1) axons were attenuated relative to the amount of myelin, (2) the axonal
atrophy was accompanied by demyelination and remyelination, (3) fibres with segmental
demyelination and/or remyelination had small axons relative to the thickness of myelin in
noninvolved internodes. They speculated that progressive axonal atrophy leads sequentially
to myelin wrinkling, nodal lengthening and myelin breakdown and remyelination. These
cellular events of axonal atrophy and secondary segmental demyelination are illustrated in
the figure 2.3-7, and have been shown to occur in an animal model of axonal atrophy and





























Figure 2.3-1: The proposed cellular events in ch¡onic neuronal iojury (cell body,
axon, or both) ofvarious types leading to axonal atrophy and secondary segmental
demyelination (From: Dyck et al. l98la)
2.3.5 AXONAL REGENERATION
Soon after focal nerve injury, regenerative events usually occur (Dyck et al. 1993, King
1994, Thomas et al. 1992, Thomas et al. 1997). Regenerating axonal sprouts arise from
intemrpted axons, grow along the Büngner bands, and may become myelinated when they
attain an appropriate size. In cross sections, several myelinated sprouts from one fibre
usually remain closely associated, forming a regenerative cluster.
2.3.6 MD(ED PATTERNS OF AXONAL DEGENERATION AND SEGMENTAL
DEl\,fYELINATION
As mentioned above, axonal degeneration can induce segmental demyelination. Conversely,
segmental demyelination also can induce axonal damage (Dyck et al. 1993). On the other
hand, the causal factors may damage myelin and axon simultaneously, and segmental
demyelination and axonal degeneration concur. Mixed patterns of segmental demyelination
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and axonal degeneration are frequently found in sural nerve biopsies and it may be difficult
to determine which is the primary injury.
2.4 SITE OF NERVE BIOPSY
As a general rule, nerye biopsies have been limited to distal nerves that meet six criteria: (l)
the nerve is affected by the neuropathic process, (2) the nerve is constant in its location and
is readily accessible, (3) either a pure sensory or a pure motor nerye, (a) long enough so
that 6 to 1Ocm of the nerve can be removed, (5) located where entrapment and pressure are
not common, and (6) suitable for conduction velocity studies in vitro (Dyck and Lofgren
1966, Dyck and Lofgren 1968, Thomas 1970a). The sural nerve meets all six criteria (Dyck
et al. 1993). The sural nerve is commonly biopsied at the level of the lateral malleolus
(Behse 1990, Cash and Blumbergs 1994, Dyck et al. 1993, King 1994, and, Thomas L97Oa)
because distal to this level, it divides into smaller branches (Behse 1990, Dyck et al. 1993)
and the pathological neuropathic changes are often more pronounced at this than at other
levels (Dy"k et al. IglIa). Biopsies of the sural nerve taken at the level of midcalf or lower
midcalf can also conveniently be combined with muscle biopsy of the gastrocnemius
(Gabreëls-Festen et al. 1992, Ferriere et al. 1985, Schroder et al. 7978, Younger et al.
1996). However, the disadvantages of this approach are that it may be more traumatic and
associated with greater neurological deficits. Quantitative morphometric studies of normal
control sural nerves have been performed on tissue obtained from necropsies, amputations
or patients with minimal evidence of peripheral neuropathy (Behse 1990, Friede and Beuche
1985a, Ferriere et al. 1985, Jacobs et al. 7985, O'sullivan and Swallow 1968, Schröder et
ql. 1978, Swallow 1966, Tohgi et al. 1977b). A fascicular biopsy is recommended by some
in order to minimize resultant sensory deficit (Dyck and Lofgren 1966, King 1994, Thomas
1970a) and avoid the risk of 'trophic' ulceration (Llewelyn et at. I99I). However, Pollock
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et ql. (1983) followed patients for five or more years after both types of sural nerve biopsy
and found no advantage of fascicular over whole-nerve removal with respect to sensory
loss' They concluded that whole nerve biopsy was surgically simpler and allowed for more
comprehensive evaluation. Since the shape of MFs is susceptible to change, it is necessary
to obtain nerve tissue as soon as possible after death or amputation. The commonest
artifacts, seen in nerves removed more than 12 hours after death, were swelling and
electron-lucency of endothelial and Schwann cell cytoplasm (Jacobs and Love 1985). In
our studies, sural nerves obtained 18-24 hours after death were found to be unsuitable for
quantitation due to artifactual splitting of the myelin sheaths.
2.5 TISSUE PREPARATION
2.5.I FD(ATION AND EMBEDDING
During tissue preparation, shrinkage is unavoidable. The fascicular area and myelinated
fibre shape are sensitive to fìxative osmolarity (Dyck et ql. 7980). Fixation by immersion in
isosmolar 2.5Yo glutaraldehyde solution and isosmolar osmium tetroxide followecl by
embedding in epoxy resin are considered to be the most suitable for morphometric study as
this minimizes the shrinkage of the fascicular area and the distortion of the shapes of MFs
(Dyck et al. 1980). When fixed in formol-saline, formol-calcium, Flemming's solution, or
hypersosmolar glutaraldehyde solution, the nerve fascicles undergo severe shrinkage, and
the shapes of fascicles and nerve fibres are distorted severely (Behse 1990, Dyck et al.
1980, Thomas 1970a, Tohgi et al. I977b). Paraffin-embedded sections are not suitable for
quantitative studies due to extensive shrinkage, severe distortion of fìbre shape, and the
thickness ofsections.
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2.5.2 THICKNESS OF TRANSVERSE SECTION
For light microscopy (LM), 0.5-1.5 ¡rm plastic (epoxy) embedded cross-sections are
commonly used for morphological and morphometric study (Cash and Blumbergs 1994,
Dyck et al. 1993, Schellens et al. L993). Thick sections, such as 5pm (Behse 1990), may
result in fibres with spuriously thick myelin sheaths and thin axons (Dyck et al. 1993). Thin
sections (a0-80nm) are often used for electron microscopy (EM) (Behse 1990, Dyck et al.
1993, Schellens e/ al. 1993).
2.5.3 STAINING
In order to enhance visualization of the myelin for LM, toluidine blue (methylene blue),
paraphenylenediamine, thionin and acridine orange are commonly used to stain specimens
(Behse 1990, Cash and Blumbergs 1994, Dyck and Lofgren 1968, Llewelyn et al. 1991,
Schellens et al. 1993, Thomas 1970a, Yita et al.l992). For EM, thin sections are often
double stained with uranyl acetate and lead citrate.
2.6 MORPHOMETRIC STUDIES
Information on sex and left-right side differences in human peripheral nerves is sparse.
Schellens et al (1993) indicated that there was no significant sex dependency in the values
for fascicular area, fibre density and number of MFs in control sural nerves at the level of
midcalf. In phrenic nerves, the number of MFs and the size of MFs were similar on both
sides (Bradley et al. 1987). O'sullivan and Swallow (1968) found that there was no
obvious difference between sexes in the mean values of myelinated fibre density in tibial and
sural nerves. The most comprehensive data was obtained by Saxod et al. (1995) who
measured the total number of myelinated fibres (TNMF), total transverse fascicular area
(TTFA) and myelinated fibre density (NÆD) of seventeen pairs of the sensory portion of the
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superficial peroneal neryes (Table 2.6-I). Fascicular area and total number of myelinated
fibres are greater on the right side, but the left and right MfO does not differ significantly.





















Abbreviations for table 2.6-I
*: data calculated from the raw data in the literature (Saxod et al. 1985)
TNMF: total number of myelinated fibres per nerve
TTFA: total transverse fascicular area per nerve
MFD: myelinated fibre density (the number of myelinated fibres per square millimeter)
SD: I standard deviation
2.6.1 THE NUMBER AND SIZE OF FASCICLES
The number of fascicles ranges between 3 and 18 per sural nerve, and is not related to age
and gender (Behse 1990, Dyck et al. 1984, Dyck et ol. 1993, Schellens et al. 1993). At the
level of the lateral malleolus, the sural nerve usually contains 5-10 fascicles (Jacobs and
Love 1985). O'Sullivan and Swallow (1968) found 230 fascicles in27 control sural nerves.
Among the 230 fascicles, 13 had a diameter less than 100¡rm, and the average diameter of
the other 217 fascicles was 0.333+0.1lmm (mean+SD), ranging from 0.056 to 0.742mm.
Jacobs and Love found that the smallest fascicle in27 control nerves was 300¡rm'in cross-
sectional area, and the largest varied from 0.03-0.06mm2 during the first few months of life
to 0.06-0.19mm2 in adults. Walsh (Ig7l) found that the fascicular area of individual
fascicles ranged from 0.02 to 0.46mm' in 3 control sural nerves. Swallow (1966) found
that age had no effect on either the number or size of the constituent fascicles of the anterior
tibial nerves.
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2.6.2 TOTAL TRANSVERSE FASCTCULAR AREA (TTFA)
Behse (1990) measured 10 control sural nerves at the level of the ankle and found that
TTFA distributed in 7-18 fascicles, ranged from 0.65-1.26mm2. Schellens et al. (1993)
found that at the level of midcalf the mean TTFA was 0.73mm2 in sural nerves with 3-4
fascicles, and 0.74mm' in nerves with 5-10 fascicles. Schellens et al. (1993) found that
TTFA increased with age in sural nerves, whereas Swallow (1966) found that the TTFA of
anterior tibial nerves was not related to age. Fascicular area is sensitive to fixative
osomolarity. This was displayed by Dyck et al. (1980) who found a I}Yo shrinkage in
fascicular area in sural nerves that had been immersion fixed in isosmolar glutaraldehyde
solution and osmium tetroxide, as compared to cryostat sections. These researchers also
showed a 43Yo shrinkage in area following fixation by hyperosmolar glutaraldehyde and
osmium. Fascicular area may increase in chronic relapsing polyneuritis (Prineas and Mcleod
1976). TTFA is greatly increased in hypertrophic neuropathies such as hereditary motor
and sensory neuropathy (type I and III), Refsum's disease and chronic inflammatory
demyelinating polyneuropathy (Dyck and Lamber| L966, Dyck et al. 1993, Gabreels et al.
1995, Thomas et al. 1997, Webster et al. 1967). Hypertrophic changes have been produced
in a variety of experimental demyelinating neuropathies and axonal neuropathies, including
lead neuropathy, recurrent compression and experimental allergic neuritis (Dyck 1969,
Lampert and Schochet 1968, Nichols et al. 1968, Pollard et al. 1975, Thomas 1970b)
(Table 2.6-2).
25
Table 2.6-2. changes of TTFA in some diseases
Disease Age Nerue NN TTFA(mm) ControlAuthor(s)
Behse ef al. 19'72











































Webster et al 1967 CNP with onion bulbs 9-65
Ohnishi et al. 19'77 ELN (3 months)
ELN (6 months)






















Abbreviations for table 2.6-2
HNLPP: hereditary neuropathy with liability to pressure palsies
EHN: experimental hypertrophic neuropathy in Sprague-Dawley rats 3 days after nerve crush
CMTIA: Charcot-Marie-Tooth disease type la (HMSNla)
ELN: experimental lead neuropatþ in Sprague-Dawley rats
S: sural nerve, (m)= at the level of midcalf; (k)= at the level of knee
P: peroneal nerve, (m)= at the level of midcalf; (k): at the level of knee
T: tibial nerve
NN: number of nerves
* calculated from the raw data in the literature
2.6.3 TOTAL NUMBER OF MYELTNATED FTBRES (TNMF)
At the level of the lateral malleolus the total number of MFs per sural nerve is usually in the
range of 4500-12000 in adult under 65 years (Behse 1990, Jacobs and Love 1985, Thomas
and Ochoa 1984). This may decrease to about 3300 after the age of 65 (Jacobs and Love
1985), or less in very old age (Behse i990). According to many researchers (Behse 1990,
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Jacobs and Love 1985, Tohgi et al. 1.g77b), the number of MFs in the sural nerve decreases
with age after 30 years. But, Schellens e/ al. (1993) reported that the total number of MFs,
with a range of 3630 to 16300 at midcalf level from 0 to 69 years, did not correlate with
age, and that the relative composition of large and small fibres remained constant over age.
In childhood, the range of the total number of MFs is 3360 lo 6920 at ankle level up to 10
years (Jacobs and Love 1985), or 2300 to 8500 at midcalf level up to 17 years (FerrieÍe et
al. I9B5). In an amputated control leg, Behse (1990) found lhal at ankle level the sural
nerve contained about 40% less MFs than did its two uniting branches at the calf 20cm
proximal to the ankle.
Loss of myelinated fibres is one of the most prominent changes in many peripheral neñ/e
disorders, such as amyotrophic lateral sclerosis (Atsumi and Miyatake 1987, Bradley et al'
1983) and diabetic neuropathy (Dyck et al. 1986a, Dyck et al. 1986b, Llewelyn et al'
l99l). If loss of MFs is more severe in distal than in proximal regions, it probably indicates
a "dying back" change (Dyck et al. l97l4 Dyck et al. 1993).
2.6.4 MYELINATED FrBRE DENSTTY (MFD)
Estimations of MFD vary considerably between researchers because endoneurial area
shrinkage may be different due to different methods of tissue preparation (Behse 1990,
Dyck et al. 1980, Tohgi et al. I977b). Severe shrinkage of fascicular area caused by
hyperosmolar fixative or parafün embedding gives rise to an increased MFD (Dyck et al.
1980, Tohgi et al. lg77b). Table 2.6-3 displays the changes in MFD produced by different
methods of tissue preparation in control sural nerves.
Myelinated fibres appear in fetal sural nerves at 15-16 weeks, rising to ZSOOO1nÑ af 36
weeks (Shield et al. 7986). MFD of sural nerves is greatest during the first few years of
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life, thereafter decreasing with age (Dyck et al. 1986b, Jacobs and Love 1985' Feniete et
ol. 19g5, O'sullivan and Swallow 1968, Schellens et al. 1993, Tohgi et al. I977b). Based
on fibre diameter distribution, Tohgi et al. (I977b) calculated MFDs of small and large
fibres respectively, and found: (a) the average small fibre density decreased rapidly from the
age of I week (26300mm2) to the second decade (9560/mm2) and continued to decrease
with age, reaching an average of 9730lmr¿ for the eighth decade, 74o/o of that for the
second decade; (b) large fibre density increased from 3 months of age, reached the
maximum average in the third decade (6480/mm2), and thereafter decreased with age,
reaching an average of 3480/mm2 for the ninth decade,54Yo of that of the third decade.
Age-related decrease of MFD is also found in laboratory and domestic animals (Grifüths
and Duncan 1988). In contrast, Saxod et at. (1985) did not find a correlation between
MFD and age in human superficial peroneal nerve. Dyck et al. (7982) measured MFD in
the sural nerve both at the midcalf and ankle level, and found that MFD decreased from
proximal to distal region.
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Table 2.6-3: Method of tissue preparation and corresponding MFD in control sural nerves
Author(s) Embed. NN MFD
Behse ef al. 1972
Dycket al. l9'7I
Ferriere et al. 1985+
Gabreëls-Festen e t al. 1992
Hamida et al. 198'7
Jacobs and Love 1985
Llewelyn et al. l99I++
Matsummuro et al. 1994




















































































Schellens et al. 1993*















Abbreviations for table 2.6-3 * midcalf level; 'r'* fascicular biopsy; # mixture
glutaraldehyde-paraformaldehyde in a phosphate buffer; Glu: glutaraldehyde; OT: osmium
tetroxide; Flemming: Flemming's solution; Embed.: embedding medium; NN: number of
neryes.
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2.6.s FIBRE DIAMETER (Ds)
On cross section, the outer diameter of myelin usually serves as the fibre diameter
(segmental diameter of the total fibre on cross section), the inner diameter of myelin sheath
usually serves as axonal diameter, as shown in figure 2.6-1. Dm is the thickness of myelin
sheath. ¡¡=(|)s-Da)/2
Figure 2.6-Lz diagram of a MF on transverse section showing Ds, Da, Dm and g-ratio
Myelinated nerve fibres in human peripheral nerye trunks range in diameter between 1 and
22pm(Thomas et ol. 1993). In control sural nerves, fibre diameters usually range from I to
18 pm. In the foetus and at birth, the frequency distribution of Ds is unimodal (Behse 1990,
Ferriere et al. 1985, Friede and Beuche 1985a, Schroder et al. 1975, Shield et ql' 1986,
Tohgi et al. 1971b,). It becomes bimodal by the 3'd month (Feniere et al. 1985), 7th month
(Tohgi et al. 1977b), or 6ú-72ú month (Friede and Beuche 1985a), and reaches adult values
by 2.5-3 (Tohgi et al. 1977b), 5 (Gutrecht and Dyck l97O),8 years of age (Behse 1990) or
14 years of age (Schröder et al. 1975). In adulthood it has a bimodal distribution with the
first or lower peak corresponding to type A-III fibres and the second or upper peak
corresponding to type A-II fibres (Auer 1994, Behse 1990, Dyck et al. 1982,Fertiete et al.
1985, Jacobs and Love 1985, Schellens et al. 1993, O'sullivan and Swallow 1968). Table
2.6-4 shows the range of Ds and positions of diameter peaks in adulthood according to
different authors. Different methods of tissue processing, primary parameter measurement,
and secondary parameter calculation probably account for the wide variance in results
reported by different investigators.
g-ratio=Da./Ds
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Table 2.6-4:Range of fibre diameter and positions of two peaks




Dyck et al. 1982
Ferriere et al. 1985*
Friede and Beuche 1985
Jacobs andLove 1985
O'Sullivan and Swallow 1968


































The composition of MFs is different between different species, different nerves, and even
between different levels of the same nerve (Dyck et al. 1982). However, the positions of
the two peaks of Ds of sural nerve at ankle and midcalf level are similar (Behse 1990, Dyck
et al. 1982). It is inferred that the myelinated fibre diameter in sural nerve attenuates 1-2
¡rm from the level of ankle to the border of the foot because the distal sural nerve
conduction velocity from the lateral border of the foot to the lateral malleolus is slower than
at midcalf (Behse 1990). The examination of the MF size spectrum can demonstrate
selective loss of particular groups of nerve fibres in pathological conditions.
With advancing age, the sural nerve loses its fibres, with the loss being predominantly in
large size fibres (O'sullivan and Swallow 1968, Tohgi et aI. 1977b). This phenomenon is
also found in anterior tibial and radial nerves (O'Sullivan and Swallow 1968, Swallow
1966). In peripheral neuropathies, the loss of MFs can be divided into three types
according to fibre size: (1) selective loss of large fibres, (2) selective loss of small fibres, (3)
loss of both large and small fibres, or general loss of MFs. General loss of MFs can be
found in many peripheral neuropathies or neurological disorders, such as diabetic autonomic
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and painful sensory neuropathy (Llewelyn et al. l99l). Nerves from patients with motor
neuron disease (Atsumi and Miyatake 1987, Bradley et al. 1983, Hamida et al. 1987),
Friedreich's ataxia (Dyck et al. 1971b), experimental organophosphate neuropathy
(Cavanagh 1964), and ischaemic neuropathy (Garven et al. 1962) show selective loss of
large fibres. Selective loss of small fibres occurs in amyloid neuropathy (Dyck and Lambert
1969), Fabry's disease (Kocen and Thomas 1970a) and painful diabetic neuropathy @rown
et al. 1976, Said et al. 1983). In amyotrophic lateral sclerosis, the total number of large
fibres and mean fibre diameter of total MFs in hypoglossal nerves were both reduced,
corresponding to the grading of the muscular atrophy of the tongue. Also the duration of
bulbar symptoms was inversely proportional to the large myelinated fibre densities (Atsumi
and Miyatake 1987). Depletion of a class of MFs may be associated with selective sensory
loss in peripheral neuropathy (Dyck et al. 1971b). The different types of diabetic
neuropathy may show selective loss of large fibres, small fibres, or general loss of both large
and small fibres (Archer et al. 1983, Behse et al. 1977, Brown et ql. 1976, Dyck et al
1986b, Llewelyn et al. 199I, Said et al. 1983). But in the studies of diabetic symmetrical
distal polyneuropathy, Dyck et al. (1986a, 1986b) concluded that selective loss of small or
large MFs are probably extremes of normal distribution and not different disorders.
Selective loss of large MFs is more coÍìmon than selective loss of small MFs.
2.6.6 AXONAL DIAMETER (Da)
Axonal diameter is determined by genetic and developmental factors, including the
synthesis, assembly, and transport of neurofilament proteins (Hoffrnan and Griffin 1993,
Ochs and Brimijoin 1993). In control human sural nerves, it ranges from 0.5pm to 7.5pm
(Behse 1990), from l¡rmto 9¡rm (Jacobs andLove 1985), from lpm to I2¡tm (Bardosi e/
al. 1987, Friede and Beuche 1985a). In the adult, its frequency distribution is also bimodal,
corresponding roughly to that of Ds (Behse 1990, Friede and Beuche 1985a, Tohgi et al.
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lg77b). Axonal diameter may be altered by various neurologic disorders and neuropathies
(Dyck et al. 1993). It also can be decreased acutely by a shift of fluid, as in hyperglycemic
hyperosmolar coma or fixation in hyperosmolar fixative (Dyck et al. 7980, Dyck et al.
1981b). Table 2.6-4 shows the changes of TNMF, MFD, and MF composition in some
neuropathies.
JJ
Table 2.6-5; Changes of TNMF, MFD, and MF composition in diseased nerves
Age Nerve NN TNMF Control tvßO(/mmz) ControlAuthor(s) Disease
Behse e/ al.1972 HNLLP
Atsumi and Miyatake 1987 ALS
Bradley et al. 1983 ALS
Hamida et at.198'7 Classical ALS
Juvenile ALS
Early onset ALS
Bardosi et al. 198'7 PNP in IMLD
PNP in JMLD
PNP inAMLD
Thomas et at.19'r.1 Uraemic NP
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Llewelyn et al. l99l
Nukada et al.1983
Matsummuro et al. 1994
Thomas et al. 1987















































































For abbreviations see next page
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Abbreviations for table 2.6-5
" percentage of total number
b calculated from the raw data in the literature
" percentage of age-related control
* mean of age-related controls: 14170 (2-5years), 13180 (6-l0years), 10530 (11-20years),9640
(21-3Oyears)
NN: number of nerves
HNLLP: hereditary neuropathy with liability to pressure palsies
ALS: amyotrophic lateral sclerosis
PNP in IMLD: peripheral neuropathy in late infantile metach¡omatic leucodystrophy
PNP in JMLD: peripheral neuropathy in juvenile metachromatic leucodystrophy
PNP in AMLD: peripheral neuropatþ in adult metach¡omatic leucodystrophy
Uremic NP: uremic neuropathy
CMTIA(I): Charcot-Marie-Tooth disease type lA (I{N{SN type Ia) with lTpl1.2-pl2 duplication
CMAIA(2): Charcot-Marie-Tooth disease typelA (I{MSN type Ia) with PMP22 point mutation
HMSN type I: hereditary motor and sensory neuropathy type I
IDD with SAN(I): insulin-dependent diabetes with severe autonomic neuropathy and an accompany
painless sensory neuropathy
IDD \ rith SAN(2): insulin-dependent diabetes with severe autonomic neuropathy and a chronic
painful sensory neuropathy
IDD with PSN: insulin-dependent diabetes with chronic or acute painfrl sensory neuropathy and no
autonomic neuropathy
IDD with PVD: insulin-dependent diabetic neuropathy with peripheral vascular disease
IDD without PVD: insulin-dependent diabetic neuropathy without peripheral vascular disease
NID with PVD: non-insulin-dependent diabetic neuropathy with peripheral vascular disease
NID without PVD: non-insulin-dependent diabetic neuropatþ without peripheral vascular disease
S: sural nerve
XII: hypoglossal nerye
Phre(l) to Phre(4): four levels of phrenic nerve from proximal to distal
CIDP : chronic infl ammatory demyelinating polyneuropathy
CDPN with MCNSD: chronic demyelinating peripheral neuropathy associated with multifocal
central nervous system demyelination
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2.6.7 THICKNESS OF MYELIN SHEATH (Dm)
Dm ranges from 0.2 to 6 ¡rm (Behse 1990, Jacobs and Love 1985, Ferriere et al. 1985) in
control sural neryes. Its distribution is bimodal in adults (Behse 1990). In the foetus, the
thickness of the myelin sheath increases gradually with the growth of the myelinated fibres
(Shield et al. 1986). From birth, Dm increases with advancing age till it reaches the adult
value at the age of 14 years (Schröder et al. 1978).
The thickness of myelin sheaths has attracted a great deal of attention. There is a positive
linear relationship between myelin sheath thickness and fibre size (Ferriere et al. 1985,
Jacobs and Love 1985, King 1994, Schröder et al. 1978). This relationship may be between
Dm and Ds (Jacobs and Love 1985), or between Dm and Da (Feniere et ql. 1985, King
1994, Sch¡öder et al. 1978). Behse (1990) and Friede and Beuche (1985) showed that the
relationship between Dm and Da is different in type-III and type-Il fibres. The relationship
between Dm and fibre calibre (Ds or Da) changed with age (Ferriere et al. 1985, Jacobs and
Love 1985, Schröder et al. 1978). In the development the axon diameter increases till 5
years of age whereas the thickness of myelin sheath increases continuously but more slowly
thanthat of the axon until 14 years of age. This asynchronous development of myelin and
axon accounts for the change of the relationship between Dm and Ds or Da with ageing
(Schröder et al. 1978).
Ultrastructural morphometric studies support a positive relationship between myelin
thickness and the size of axon (Arbuthnott et al. 1980, Boyd and Kalu 1973, Friede 1972,
Friede and Samorajski 1967). The myelin sheath consists of a number of myelin lamellae
with a radial periodicity of l2-l7nm in fixed nerve, and 17-18nm in unfixed nerve (Kittg
1994, Thomas et al. 1993). The number of myelin lamellae is linearly related to axonal
circumference (Arbuthnott et al. 1980, Boyd and Kalu 1973, Dyck et ql. lgTla,Dyck et al.
5t
IgTlc,Friede and Samorajski 1967). In the mouse, there was one lamella for every 0.24¡tm
increase in axon circumference (Friede and Samorajski 1967). In the cat, Arbuthnott et al.
(1980) found that the equation m:0.103s-0.26 (m: the thickness of the myelin sheath; s:
axonal perimeter) was an accurate representation of group II, III and y fibre. In the
development of peripheral nerves, retardation of axon growth retarded myelin sheath
growth, and acceleration of axon growth accelerated myelin sheath growth (Friede 1972).
Dyck and co-workers found (I971a,1971b) that around the atrophic axons in uraemic and
Friedreich's ataxic neuropathies the number and periodicity of myelin lamellae remained
relatively constantly. The number and periodicity of myelin lamellae also remained
unchanged in axonal enlargement due to polyglucosan disease despite an increase in the
myelin sheath spiral length (Yoshikawa, et al. 1990). In experimental axonal atrophy, the
myelin lamellar number also remained unchanged (O'Neil et al. 1984, O'Neil and Glliatt
1987). Dyck et al. (l97lb) found no correlation between the axonal circumference and the
number of myelin lamellae in the sural nerves from patients with Déjérine-Sottas
hypertrophic neuropathy although the number of myelin lamellae per fibre was less than that
of control fibres of the same axonal size (Dyck et al. 1970).
Morphometric approaches have been used to assess axonal atrophy or shrinkage in various
experimental and human neuropathies (Dyck et al. l97la, Dyck et al. 1977b, Dyck et al.
1980, Dyck et al. 1981a, Dyck et at. 1981b, Dyck et al. 7985, Dyck et al. 1993, Engelstad
et al. 1997, Gabreëls-Festen et al. 1992, Gabreels-Festen et ql. 1995, Jakobsen 7976,
Llewelyn et al. l99L). Is it possible to distinguish primary from secondary demyelination by
morphometric methods? This question is complicated, and needs more study.
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2.6.8 G-RATIO
The g-ratio is the quotient of axonal diameter/fibre diameter (Schmitt and Bear 1937), and
ranges from 0.4 to 0.9 in human sural nerve (Behse 1990, Friede and Beuche 1985a). The
relationship between the g-ratio and fibre size is complicated. Sunderland and Roche
(1958) lound that the g-ratio increased continuously with increase of fibre diameter, but
Buchthal and Rosenfalck (1966) found, on the contrary, that the g-ratio was decreased in
the largest fibre groups. Behse (1990) and Friede and Beuche (1985) found that the g-ratio
increased with fibre diameter in a parabolic fashion, and that the small fibres had a larger
mean g-ratio than the large fibres. According to Behse (1990) about two thirds of large
fibres in the control sural nerve had a g-ratio around 0.6. These conflicting results may be
due to different morphometric methodologies and different sample size. In childhood, the
g-ratio decreases with age (Friede and Beuche 1985a) due to the asynchronous
development of myelin and axon (Schröder et al. 1978).
The g-ratio, as well as myelin thickness, are often used to detect axonal atrophy and
secondary demyelination (Engelstad et al. 1997, Gabreëls-Festen et al. 7992, Gabreels-
Festen etal 1995,Llewelyn etal. 1991, Schröder et al. 1978). Previous reports on g-ratios
in peripheral nerve diseases are summarized in table2.6-6.
Table 2.6-6', G-ratio in peripheral nerve disease
Author(s) Disease age(ys) Nerve NN G-ratio Control









































Abbreviations for table2.6-6 see next page
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Abbreviations for table 2.6-6
*calculated from the raw data in the literature
NN: number of nerves
PNP in IMLD: peripheral neuropathy in late infantile metachromatic leucodystrophy
PNP in JMLD: peripheral neuropatþ in juvenile metachromatic leucodystrophy
PNP in AMLD: peripheral neuropathy in adult metach¡omatic leucodystrophy
CMAIA(1): Charcot-Marie-Tooth disease type lA (HMSN type Ia) with lTpl1.2-pI2 duplication
CMAIA(2): Charcot-Marie-Tooth disease typelA (I{MSN type Ia) with PMP22 point mutation
2.7 QUANTITATING METHODS
Manual-mechanical measurement on enlargement photomicrographs
This method was time-consuming and inaccurate, and for these reasons is of historical
interest only (Espir and Harding 196l,Dyck et al. ),993)
Digitizing methods
The development of digitizing tablets and microprocessors allowed peripheral nerves to be
quantified using either enlarged photomicrographs or camera lucida drawings (Behse 1990,
Cavallari et al. 7989, Dyck et al. 1993, Ewart et al. 1,989, Fraher 1980, Lipski and Martin-
Body 1987, Hahn et al. 1987, Gago et al. 1988, Naus et al. 1987, Tohgi et al. 1.977b).
However, digitizing methods still required manual attention to individual nerve fibres with
the possibility of operator bias during measurement.
Computer-assisted image analysis system
The development of computer and image analysis systems allows automatic morphometric
assessment of myelinated nerve fibres. Zimmerman et al. (1980) developed the first system
based on computerized image analysis. Yita et al. (1992) and Auer (1994) developed
systems that can recognize, enumerate, and evaluate the sizes and shapes of transverse
nerve fibre profiles automatically.
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The hardware components of a computer-assisted image analysis system consist principally
of a personal computer with hard disk drive and mouse, video camera, image monitor, light
microscope with variotube and C-mount adaptor for video-camera, and cables for
connecting monitor to computer (Auer 1994, Cavallari et al. 1989, Torch et al. 1989b, Vita
et al. 1992, Zimmerman et al. 1980).
The software for myelinated fibre quantitation in peripheral nerves is variable according to
researcher or company, but the mechanism of myelinated fibre morphometry is
similar-based on operator-interactive selection of colour value limits. Through the light
microscope and a variotube, the image of endoneurium is magnified onto a video camera.
Every measuring frame is divided into many Myelinated fibre is conducted as a function of
pixel brightness. Each point of the analysed image is coded into 256 grey-scale levels. On
fixed and stained nerve sections, myelin sheaths appear as dark objects on a bright
background and consequently pixels whose grey-level values are less than the threshold
value chosen by the operator are considered to belong to myelin sheaths. Conversely, the
remaining pixels, whose greyJevel values are greater than this threshold value, are
considered as non-myelin structures. The original image is then transformed to a binary
image (or logic mask) of the myelin sheath. Inversion of the image generates a logic mask
of the axon, and this inversion leads to the construction of a logic mask for the myelinated
fibre. The myelin sheath masks, fibre masks and the corresponding axon masks are
extracted one by one from the fibre binary image and the measurements of the myelin sheath
area, fibre area, axon area, the inner and the outer perimeter of the myelin sheath are made
on the myelin sheath binary masks, fibre binary masks and the axon binary masks,
respectively. Data are stored on disk for further calculation. Operator-interaction is
necessary for the available image analysis system to eliminate large Schwann cell nuclei,
dust particles and stain crystals, erase dark degenerated fibres, separate touching fibres and
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correct the profiles of fibres with pale myelin sheaths. Judgement is according to
histological criteria on video screen (Auer 1994, Cavallari et al. 1989, Torch et al. 1989b,
Yita et al. 1992, Zimmerman et al. 1980, Leica Quantimet 500MC User Manual, Leica
Quantimet 600 User Manual).
Computer imaging has a number of advantages in determining the number, size, shape, and
distribution of MFs and their components: it is speedy, measures the perimeter and area
precisely, automatically quantifies on average not less than 85% MFs in each measuring
frame, excludes operator bias, and eliminates the step of photographic processing (Auer
l994,Dycket al. 1993,Yitaet al. 1992).
However, no completely automatic method is currently available because some problems
have yet to be resolved.
(1) Operator intervention is still necessary in order to eliminate unwanted structures, such as
Schwann cell nuclei and stain particles (Auer 1994, Yita et al. 1992). This difüculty can be
resolved by quantiSing MFs in specimens only after osmium tetroxide postfixation without
further staining. Dyck and Lofgren (1968) first fixed the specimen in glutaraldehyde,
postfixed with 1% buffered osmium tetroxide, and then examined the specimen using phase
contrast microscopy. But phase contrast microscope needs a relatively thick (l.5pm)
section, and this may result in fibres spurious thick myelin sheaths and thin axon as
mentioned above.
(2) Manual movement of the microscope stage is necessary to alter the measuring frame.
Using an automatic microscopic stage would partly overcome this problem. However, this
would require the computer to have the ability to recognize the perineurium, know when to
change frames, and know when to end quantif,iing. These technical difüculties are still to be
overcome.
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(3) The problem of Schmidt-Lanterman clefts. The Schmidt-Lanterman cleft is part of the
normal structure of a myelinated fibre (Thomas et al. 1993), The number of these clefts is
directly related to the myelin thickness or fìbre diameter (Buchthal et al. 1987, Friede and
Samorajski 1969, Ghabriel and Allt 1979, Ghabriel and Allt 1980). In human sural nerves,
Schmidt-Lanterman clefts amount to nearly 50Yo of the internode length in large fibres and
up to 6Yo in small fibres (Buchthal et al. 1987). In previous morphometric studies
investigators manually excluded fibres cut through the Schmidt-Lanterman cleft when
considering fibre calibers and relative thickness of the myelin sheath (Behse 1990, Llewelyn
et al 1991), or considered them as 'double-sheathed' fibres (Torch et al. 1989). Auer
(1994) and Vita et al. (1992) did not address the question of how to deal with such fibres
using automatic methods of quantitation. V/ith the Quantimet 500MC (Leica-Cambridge,
UK), the clefts were usually so small in normal sural nerve that the computerized image
analyzer mistook them as part of the myelin sheath. However, in diseased nerves, especially
in some severe axonal atrophic nerves, the width of the clefts became larger and clearer, and
the image analyzer sometimes considered one fibre cut through a wide Schmidt-Lanterman
cleft to be two concentric fibres.
(4) How to deal with degenerating fibres? Both the myelin and axons of degenerating fibres
appear as dark structure. Yita et al. (1992) manually erased these fibres. Other researchers
have not discussed how they dealt with these fibres.
(5) The methods of Auer (1994) and Vita (1992) require manual separation of fibres that
are close to each other, especially clusters of regenerating fibres. Otherwise fibres that
touch each other are measured as distorted larger fibre(s).
(6) When using the method of Auer (1994), the measured perimeter of some diseased nerve
fibres may be larger than they should be because the image system also includes in its
measurement clefts and myelin sheath folds.
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(7) Automatic methods still lose 100á-15% fibres, including fibres cut through the node of
Ranvier and some pale fibres (Auer 1994, Dyck et al. 1993, Vita 1992, Zimmerman et al.
1980) which may be regenerating or remyelinating fibres.
Calculation of fibre and axonal diameter
On a transverse section, the most common parameters used to depict the size of MFs are
the segmental fibre diameter (Ds) and the axonal diameter (Da). In the in vivo state, the
shape of MFs in transverse section is assumed near-circular, and myelin is semi liquid (Dyck
et al. 1993, King 1.994). Distortions of nerve fibres occur during the processing of samples
(Behse 1990, Dyck et al. 198Q Karnes et al. L977). During quantitation, many primary
parameters can be measured directly from each individual MF, such as: the long axis
(longest distance across the fibre), the short axis (greatest distance across the fibre at right
angles to the long axis or the distance across the center of the fibre at right angles to the
long axis), the perimeters of the outer edge and inner edge of myelin sheath, the area of
myelin sheath, the area of axon, and the area of the total fibre on cross section (Auer 1994,
Behse 1990, Cavallari et al. 1989, Dyck et al. 7993, Karnes et al. 1977, Vita et al, 1992).
In earlier studies, the long axis, the short axis, and the arithmetic or geometric mean of the
long and the short axis were used to represent fibre caliber (Behse 1990, Blight and
Decrescito 1986, Cavallari et al. 7989, Chaia et al. 1987, Dunn et al. 1975, Karnes 7977,
Mackinnon et al. 1986, Tomanek and Tipton 1967). These parameters are no longer
employed to represent the fibre diameter as they are inaccurate (Karnes et al. 1977,Dyck et
al. 1993). Currently, three kinds of methods are comtnonly used to calculate Ds and Da.
They are shown in table 2.7-7. These methods are all based on primary parameters which
are directly measured using a digitizer or image system.
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Table 2.7-1. Three methods of calculating fibre and axonal diameter
Method Formula Author
(1) area-equivalent circle (a) Ds :2ßr- Yita et al. (1992)
Da= Z'llraln
(b) Da :2.l1roln Zimmerman et al. (1980)
Ds : Da + 2Dm Dyck and Karnes (1981)
Advantage: Diameters derived from area measurements show the greatest precision and accurary, with
the least bias (Karnes et al. 1971).
Disadvantage: The above equations were derived wing 2%o Glutamldehyde solution fixed nerves, and
there was no comparison with fresh or cryostat sections, or between different methods of fixation
to assess whetler there is any difference in the degrees of shrinkage between myelin sheaths and
axoplasm. Dm is not uniform on cross section, especially in nerves showing pathological
changes.
(2) perimeter-equivalent circle (a) Ds : Ps/æ Friede and Beuche (1985)
Da=Paln Torch et al. (1989)
(b) Da =Paln
Ds = Da + Dm* Llewelyn et al. (1991)
Advantage: Myelin sheath perimeters remain relatively constant dwing processing of newe tissue @yck
et al. 1980).
Disadvantage: Even in a healthy nerve, the shape of a fibre is not strictly circular. It may be boomerang
shaped in the Schwann cell nuclear region, or crenated in the paranodal region ffarnes et al.
1977). In diseased nerves with myelin sheath splitting, the computer image system may measure
the perimeter along the cleft of splitting which results in an incorrectly long perimeter (our
experience with Quantimet 500MC system). When the axon is atrophied, the myelin sheath may
be folded complexly, and the axon may lose its circularity (O'Neil and Gilliatt 1985). This
results in an increase in the perimeter as the computer image system measures along the uneven
edge of myelin sheath.
(3) Based on area and perimeter ps : (0.5P + 2nÃmlP)l x Auer (1994)
Da: (0.5P - Zn{mlP)l n
Advantage: The perimeters of the myelin sheath and area of the myelin sheath remain relatively
constant during tissue preparation (Auer 1994, Dyck et al. 1980).
Disadvantage: The same as in (2).
Abbreviations for table 2.7-l see next page.
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Abb reviations for T able 2.7 -7
Bold letter: primary parameter, obtained from measuring directly
Ds: segmental fibre diameter on transverse section
Da: a;<onal diameter
Dm: myelin sheath thickness
Ps: segmental ñbre perimeter on transverse section: perimeter of the external edge of myelin sheath
Pa: axonal perimeter = perimeter of the internal edge of myelin sheath
P: sum of the external and internal perimeters of myelin sheath: ps * Pa
Aa: axonal area on cross section = area enclosed by myelin sheath
Am: area of myelin sheath
As: transverse area of the internodal segment
Dm*: number of myelin lamellae x myelin spacing factor, the latter obtained by counting the
number of myelin lamellae over a given width,
All three methods rely on the assumptions that the area enclosed by the myelin sheath
includes only the area of axoplasm and that the perimeter of the internal edge of myelin
sheath is the perimeter of axon. In healthy nerve this assumption is acceptable because the
adaxonal space, or periaxonal submyelinic space is so small, approximately 200Ä. (Thomas
et al. 7997, Waxman 1985), that it can be ignored, and the shape of axon is near circular.
But in axonal atrophic fibres, the adaxonal space increases and must be taken into account.
Diameters derived from measured areas, perimeters, or combined areas and perimeters have
disadvantages that have not yet been overcome. Therefore, it is more accurate to use the
total fibre area on cross section (As), the myelin sheath area (Am), and the axonal area (Aa)




The aims of this project were to âssess the accuracy of quantitative studies of
myelinated nerve fîbres obtained by fascicle and systematic sampling methods and
determine the minimal sample size that would result in an accurate representation of
the whole myelinated fibre population.
The total number of MF (TNA/ß) in a normal sural nerye varies between 3300-12300 at the
level of ankle (Behse 1990, Jacobs and Love 1985), and between 3630-16330 at the level of
midcalf (Schellens et al. 1993). Even with the help of a computer-assisted image analyzer,
it is time-consuming to measure all the myelinated fibres. In the past, various sampling
methods were used to overcome this problem often only measuring a few hundred
myelinated fibres of myelinated fibres within a fascicular area of approximately 0.1mm2
(Auer 1994, Behse 1990, Jacobs and Love 1985, Vita et al. 1990, Schellens et ø1. 1993).
However, the spatial distributions of the number and size of myelinated fibres are non-
uniform within and between fascicles in peripheral nerves @yck et al. 1984, Dyck et al.
1986a, Dyck et al. 1986b, Saxod et al. 1985, Torch et sl. 1989a), and pathological changes
may be focal, multifocal, or diffi¡se (Dyck et al 1993). Therefore, morphometric results
from an unsuitable sample may not be reliable.
The main aim of this study was to establish the minimal total transverse fascicular area that
should be quantified in sural nerves in order to obtain data that is comparable to (and















1. Quantitation of myelinated nerve fibres in one fascicle or part of a fascicle/s is not an
accurate representation of the whole myelinated fibre population in the sural nerye.
2. Myelinated fibres in more than half of the fascicular area in every fascicle need to be
counted in order to acquire results comparable to that of counting the whole myelinated
fibre population in the sural nerve,
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CIIAPTER 3: MATERTALS AND METHODS
3.1 SELECTION OF MATERIALS









3.6.2 Systematic Sampling of Every nth Measuring Frame
3.7 DISTRIBUTION OF MYELINATED FIBRE DENSITY AND FIBRE SIZE
3.T.L Distribution of Myelinated Fibre Density


















3.1 SELECTION OF MATERIALS
Eighteen sural nerve biopsies examined in the Neuropathology Section of the Institute of
Medical and Veterinary Science (Adelaide) were randomly selected for quantitative studies
on myelinated nerve fibres. Two sural nerves taken at necropsy from a subject without
evidence of peripheral nerve disease served as normal controls. The clinical features of this
subject and the pathological cases, including electrophysiological findings where available,
are detailed in table 3.1-1.
The morphological studies on these 20 sural nerves are displayed in table 3.I-2. All the 18
pathological nerves showed different degrees of demyelination/remyelination with or
without axonal degeneration.
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Table 3.1-1. Summary of the clinical features of the patients whose sural nerves were used in this study











































































road traffic accident, heroin addiction
?CIDP, ?HMSN
IgM paraproteinaemic neuropatþ





amputation due to ischaemia
following legionella pneumonia
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Table 3.1-l (continued): Summary of the clinical features of the patients whose sural nerves were used in this study















Abbreviations for table 3.1-1.
PM: postmortem
NCV: nerve conduction velocity
SNAP: sensory nerve action potential
not done: nerve conduction studies not performed
CIDP : chronic inflammatory demyelinating polyneuropathy
HMSN: hereditary motor and sensory neuropathy
motor neuropathy









































Plastic lpm sections (T.S + L.S) +EM
MF loss ax. degen. demyel. remyel. EF
Tabte 3.1-2: Pathological Features
Teased Nerve Fibres
inflam. cells percentage of the total number of teased fibres
N/A
N/A
Z3Yodemy el. /remyel. and 3o/o axonal degen.
N/A
++ 44Yo demyel./remyel. and 5Yo axonal degen.
+++ +++ 260/o demyel./remyel. and llYo axonal degen.
++ 92%o demyel./remyel
++ 43Yo demyel./remyel. andZYo axonal degen.
25Yo demyel./remyel. and2Yo axonal degen.
52o/o demyel./remyel. and 2Yo axonal degen.











































18% demyel./remyel. and lTYo axonal degen.
15% demyel./remyel. and73o/o axonal degen.





38% demyel./remyel. andTYo axonal degen.
Nerve Plastic lpm sections (T.S + L.S) +EM
MF loss ax. degen. demyel. remyel. EF
Teased Nerve Fibres
inflam. cells percentage of the total number of teased fibres
+++ 22Yo demyel./remyel. and 1'7Yo axonal degen.
# 79'o demyeL /remyel. and 78o/o axonal degen.
ZlYo demyel./remyel. andTYo axonal degen.







19 +# + +#
20 +++ + ++ +# +
* The morphological findings are reported by Dr. P.C. Blumbergs and Dr. G. Scott.





T. S+L. S : transverse and longitudinal sections
EM: electron microscope
MF:myelinated fibre




inflam. cells: inflammatory cells
+
54
3.2 SURAL NBRVE BIOPSY
The sural nerve biopsies were performed according to a standard protocol (Cash and
Blumbergs Igg4). Under local anaesthesia, an incision of about 8cm was made in the
furrow just behind and above the lateral malleolus. The sural nerve was exposed and
approximately a 6cm length of nerve was excised and placed directly onto a sheet of dental
wax. Extreme care was taken in the process of biopsy in order to avoid nerve crushing and
stretching.
3.3 TISSUE PREPARATION
The sural nerve biopsies were examined according to routine methods currently used in our
laboratory (Cash and Blumbergs 1994). The methods are described briefly below.
After removal from the body, the nerve is placed directly on to a sheet of dental wax for
further dissection with a razor blade. One 2mm specimen orientated in the transverse plane
is placed in a blob of O.C.T. (Tissue Tek) on a piece of cork with a needle in one corner.
This is plunged into isopentane pre-cooled by liquid nitrogen in an upright position to be
frozen. Then it is stored in liquid nitrogen for frozen section. Five-micron cross sections
are cut and stained with H&E for morphological studies. Two 2mm specimens are put into
10olo formal-saline for no less than 4 hours, and then embedded in paraffin. Five-micron
cross sections are cut and stained with H&E, trichrome and congo red for morphological
study. One 3 to 4 cm long specimen is secured at each end with cotton. A 59 stainless
steel weight is attached to one end of thetissue, and it is suspendedin2.5Yo glutaraldehyde
(in 0.05 mol/l cacodylate buffer) for 1.5 hours. Then the nerve is separated from the weight
and dissected into smaller segments, 2mm in length for electron microscopy, 2mm in length
oriented transversely for resin embedment and light microscopy, 4mm in length orientated
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longitudinally for resin embedment and light microscopy and 15 to 20mm in length for
teasing. Blocks for resin embedding and light microscopy remain in glutaraldehyde
overnight and are washed in 0.05 moVl sodium cacodylate buffer for at least half an hour
with 5 changes of buffer. Then the specimens are processed as indicated in table 3.3-1.
Semithin sections are cut at lprm, with care to ensure they are precisely transverse, using a
mlcrotome.
Table 3.3-1. Resin processing schedule for nerue specimens










10á aqueous osmium tetroxide





Propylene oxide: epo)ry resin (1:1)












Two changes, each of I hour
(under vacuum)
Overnight (under vacuum)




12 Embedded in resin
13 polymerize at70oC overnight
After a further half an hour fixation in glutaraldehyde, the segment for teasing fibres is
separated into fascicles. The fascicles are washed in buffer for at least half an hour with
several changes of buffer. Then the specimens are processed as indicated in table 3.3-2.
56
Table 3.9-2. Processing schedule for teased fibre preparations






lo% aqueous osmium tetroxide









Teased fibres were prepared by Kathy Cash.
3.4 STAINING METHODS
On micron resin cross sections were stained with 1olo aqueous osmium tetroxide (step 1 of
nerve processing schedule in table 3.3-1) and no additional staining of MFs was undertaken'
In such preparations, the myelin sheaths were dark grey rings, while the other structures
were colourless. One micron resin cross and longitudinal sections stained with toluidine
blue, and 5¡rm parafün cross sections stained with H&E, Trichrome, and Congo Red were
used for morphological examination.
3.s QUANTTTATION
One micron resin cross sections were used for quantitation. These were prepared according
to the protocol outlined in table 3.3-I, and apart from staining with 1oá aqueous osmium
tetroxide as part of the preparation, no other staining techniques were employed.
3.5.1 IMAGE SYSTEM
Quantimet 500MC computer-assisted image analysis system (Leica-Cambridge, UK) was
used for quantitation. The Quantimet 500MC system allows customer programming of
image analysis function. The software for automatic nerye fibre quantitation was written by
Peter Smith and Ian Parkinson. The sequence for nerve quantitation is explained below.
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3.s.2 QUANTTTATTNG METHODS
Under low magnification, each fascicle was numbered. Using an oil lens (100x), a3.3x
tube, and a Sony CCD-camera (charge coupled device-camera), the image of the nerve was
displayed onto a video display. A rectangular frame defines the measuring frame on the
video image. According to the manufacturer of the image analysis system (Leica-
Cambridge, UK), each measuring frame contains 202500 (405x500) pixels, and when the
image of the nerve is magnified 3018 times, each pixel equals to 0.11mm along its edge.
Dyck et al. (L984) suggested that the final magnification of about x2000 is suitable for
determining the fibre size, shape and fibre density. In a previous study we found that of this
magnification (x2000) our image analysis system lost some small fibres and some fibres
touched each other. However these problems \/ere reduced at a magnification of x3018.
The intrafascicular area of each fascicle was divided into rectangular measuring frames
@igure 3.5-14). Beginning with the upper left corner of each fascicle, fibres in the field of
each measuring frame were quantitated and measured only if the lowest pixel of the fibre is
within the measuring frame. Otherwise, it was measured in the adjoining field (Figure 3.5-
1B). In Figure 3.5-18, fibre x was measured in this field, and fibre y would be measured in
the adjoining field. Each horizontal field was measured in sequence until more than half of
the measuring frame was occupied by subperineurial space or perineurium, at which time
the field was shifted one frame down and continuous fields were counted in the opposite
direction until the whole fascicle had been examined. Artifacts produced in nerve biopsy










Figure 3.5-1: (A) Diagram of a fascicle that is divided into 36 rectangular
measuring frames. (B) Magnification of one measuring frame. According
to the set-up of the manufacturer, the area of the measuring frame is 202500
(405x500) pixels, equal to 2450¡tm2.
According to the manufacturer, the microcomputer-based image analysis system (Leica-
Cambridge, UK) receives a digitized image from the CCD-camera at 256 grey levels.
Threshold was adjusted to capture only the dark grey myelin sheaths and generate binary
images. The number of MFs within each field and the number of measuring frames within
each fascicle were counted and stored on an Excel spreadsheet. For each identified MF the
following measurements were made: (1) long aús (longest distance across fibre); (2) short
axis (distance across the center of the fibre at right angles to the long axis); (3) area of
myelin sheath (Am); (4) sum of perimeters (P) of external (Po) and internal (Pi) edge of
myelin sheath. The Po was thought to be the fibre perimeter (Ps) on cross section, and the
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Pi to be the axonal perimeter (Pa). The derived parameters were calculated using Visual
Basic for Excel program, written by Ian Parkinson specifically for this purpose.
3.5.3 PARAMETER TRANSFORMATION
In vivo, the shape of myelinated fibres on transverse section is assumed to be nearly
circular. During processing, there is shrinkage of the fascicles. The shapes of MFs are
distorted, and become irregular. However, the area and perimeter of the myelin sheath
remain relatively constant (Auer 7994,Dyck et al. 1980, Karnes et al. 1978). The contour
of MF on cross section was converted into a myelin sheath area and perimeter-equivalent
circle (Figure 3.5-2).
Figure 3.5-22 Transformation of the shape of MF on cross section
myelin area equivalent
Ds_-
The fibre diameter (Ds) and axonal diameter were assumed to be equivalent to the outer
and the inner diameter of the myelin sheath respectively, and were determined
mathematically from Am and P (Auer 1994).
(l) Fascicular area of each fascicle : 2450pm2xthe number of measuring frames of each
fascicle
(2) TTFA: sum of the fascicular area of every fascicle within one nerve
(3) mean MFD: calculated from the number of MFs in each measuring frame
(a) Fibre diameter and axonal diameter: |s:(0.5P+2æÃmtP)/æ
P¡:(0.5P-Zx{mtP)ltr
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Ds : Ps/n : (0.5P+ 2 tAm/P)/n
D a -- P a/ r : (P - P Ð / r : (P - (0. 5 p + 2 tuLm/P) / n : (0' 5 P- 2 ttAm/P) / n
In peripheral nervous system, myelinated fibres are bigger than 1¡rm in diameter (Thomas el




Data from each fascicle forms a sample. The TNMF, TFA MFD, Ds, and Da of each
fascicle were quantitated, and the data for each fascicle compared to that of the whole
myelinated nerve fibre population. In this way, fascicular representation of the whole MF
population was assessed.
3.6.2 SYSTEMATIC SAMPLING OF EVERY Nth MEASURING FRAME
A Visual Basic for Excel program was written for this purpose by Ian Parkinson to allow
the user to extract data from every 2n0,3'0,4^, ......, 10* measuring frame from every
fascicle to form 9 samples for each nerve. This allows investigation of whether data from
lOyo to 50% TTFA can reliably represent the whole population. Because the first
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measuring frame was usually incomplete, we began with the 2"d field in every fascicle. For
example, every 5û field sample contains the 2"d,7ú, lzh, 17^ ,......measuring frame in
every fascicle (bold digits in figure 3.5-14) within one nerve.
3.7 DISTRIBUTION OF MYELINATED FIBRE DENSITY AND
FIBRE SIZE
3.7.1 DISTRIBUTION OF MYELINATED FIBRE DENSITY (MFD)
MFD is usually expressed as the number of MFs per mm'. In these studies, MFD was also
expressed as the number of MFs per measuring frame to provide a measure of its frequency
distribution, which may be expressed via histograms.
3.7.2 DISTRIBUTION OF MYELINATED FIBRE DIAMETER AND AXONAL
DIAMETER
By convention, the histogram repreòenting fibre diameter distribution is generated as the
graphical representation of the number of myelinated fibres per micrometer-bin. A binwidth
of lmicron is used mostly, as it provides a compromise between loss of detail and limited
precision of the individual bin value (Olson 1973). In this way, the histograms of both fibre
diameter and axonal diameter are described with 2I parameters, 0-20¡rm and larger than
20pm.
3.8 STATISTICAL METHODS
The data were expressed as mean values and standard deviations (SD). Visual inspection of
the histograms of the distribution of sum of the axonal and nerve fibre perimeters, myelin
sheath area, fibre diameters and inner diameters of myelin sheath were not Gaussian,
whereas the distribution of MFD was near Gaussian. In order to achieve uniformity, the
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differences were evaluated using non-parametric tests. Differences between samples and
the whole population were evaluated using Wilcoxon Rank-Sum and Komolgorov-Smirnov
tests with SAS software.
The Wilcoxon Rank-Sum test compares the mean values of one sample with another. The
Kolmogorov-Smirnov goodness of fit test compares the shape of cumulative frequency
distributions. Samples were derived either from the whole fascicle or the systematic
sampling methods and were compared with the mean fibre density, mean fibre diameter and
axonal diameter, and the distributions of these measurements derived from measurement of
the entire MF population of the whole nerve.
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4.1 GENERAL DESCRIPTION OF THE \ryHOLE NERVES
The number of fascicles (NF), total number of myelinated fibres (TNMF), total transverse
fascicular area (TTFA), myelinated fibre density (NßD), fibre diameter @s), and axonal
diameter (Da) of each sural nerve are displayed in table 4. I - 1 (see p7 1).
4.1.1 FREQUENCY DISTRIBUTION OF MYELINATED FIBRE DENSITY (MFD)
The frequency distribution of MFD of all sural nerves is depicted in figure 4.l-1 (see pp72-
75). In these figures, MFD is expressed as the number of myelinated fibres (MFs) per
measuring frame. Each measuring frame has an area of 2450¡tm2. The MF count for each
measuring frame ranged from 0-28 (Figure 4.1-1). By convention, the MFD is expressed as
the number of myelinated fibres lmm2. The mean MFD, calculated from each measuring
frame, was 4,934 and 5785/mm2 in the two control nerves, and averaged 3,73Ilmm2 in the
l8 pathological nerves (Table 4.I-I, see p71). It can be seen that frequency distribution of
MFD is near Gaussian for all sural nerves in this study.
4.1.2 FREQUENCY DISTRIBUTION OF FIBRE DIAMETER (Ds)
The frequency distributions of fibre diameter are expressed and displayed as percentage
frequency histograms for each nerve in figure 4.1-2 (see pp76-79). In the 2 control nerves
(nerve No.1 and 2), the frequency distribution of fibre diameter is bimodal with the first
peak at 4-6pm corresponding to type-III fibres, and the second peak at 11-14¡rm
corresponding to type-Il fibres. A trough is evident at 8-9pm In the pathological group,
the bimodal distribution of fibre diameter is retained in nerves No.3, 4,5,6,9, 10, lI, 12,
13, 14, 15, 16, 17, 18, and 19 despite loss of larger diameter fibres in some nerves. In
nerves No.7, 8 and 20, there is greater loss of larger diameter groups giving a unimodal
appearance
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4.1.3 FREQUENCY DISTRIBUTION OF AXONAL DIAMETER (Da)
The frequency distribution of axonal diameter is expressed as a percentage frequency
histogram, and displayed in Figure 4.1-3 (see pp80-83). In the two control nerves, the
distribution of axonal diameter is bimodal with the first peak at 4-5¡tm, and the second peak
at 7-8¡rm. This corresponds to the distribution of fibre diameter. The first peak of Da
represents type-III fibres, and the second peak represents type-Il fibres. In the pathological
group, only two sural nerves have an obviously bimodal distribution of axonal diameter
O{o.3 and 14). The others have a unimodal or indeterminate distribution ofDa.
4.2 COMPARISON OF MYELINATED FIBRE DENSITY (MFD)
OBTAINED BY FASCICLE AND SYSTEMATIC SAMPLING
METHODS TO THAT OF THE WHOLE MYELII\ATED FIBRE
POPULATION
Results of the number of myelinated fìbres (NMF), transverse fascicular area (TFA" mm')
and the percentage of total transverse fascicular area (YoTTFA), and myelinated fibre
density (l\ßD) (/mm2) of each sampling group, and the comparison of MFD to that of the
whole myelinated fibre population of the twenty sural nerves are displayed in tables 4.2-I to
4.2-20 (see pp84-93). Each table corresponds to one nerve, table 4.2-l to nerve No.1, table
4.2-2to nerveNo.2, and so on.
4.2.1 FASCICLE SAMPLING
Because the frequency and the spatial distribution of myelinated fibres in the different
fascicles are heterogeneous between fascicles, it is necessary to investigate i) whether the
mean MFD within a fascicle is influenced by fascicular size and, ii) whether the MFD of a
fascicle is comparable to the MFD of the whole nerve.
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i) Comparison of Myelinated Fibre Density (MFD) Among Fascicles
The mean values and spatial distribution of MFD varied considerably between fascicles in
both control and pathological nerves. To test the hypothesis that fascicle size is a function
of MFD (Saxod et al. 1985), fascicle size (diameter and fascicular area) was plotted against
mean MFD. Figure 4.2-1 (see p95) shows scatter diagrams from 6 nerves, including 2
control nerves (No.l and 2),2 mildly pathological nerves C{o 3 and 4) and 2 pathological
nerves (No.5 and 6). The coefficients of determination (n) of ünear regression between
mean MFD of each fascicle and its fascicular area or fascicle diameter are also shown in the
figure. There is no correlation between fascicle size (either diameter or area) of each
fascicle and its mean MFD in the 6 nerves. We also did not find any relationship between
MFD and fascicle size in the other 14 pathological nerves.
ii) Comparison of Myelinated Fibre Density of Fascicles With the Whole Myelinated
Fibre Population
The percentage of fascicles in which the mean value and shape of the frequency distribution
of MFD differed significantly from that of the whole nerve is shown in table 4 2-21 (see
p96). The MFD of the sample differs from the whole population if either the mean MFD or
MFD frequency distribution is significantly different. In only one of the 20 nerves (nerve
No.5), were the MFDs of all the fascicles comparable to the whole population. In the two
control nerves, there were a total of 14 fascicles, of which 8 (57.I%) had MFDs that were
significantly different to the whole population. In the 18 pathological nerves, there were
168 fascicles, of which 61 had significantly different MFDs. The findings were similar in
control and pathological groups (Chi-square test, P:0.1580; Fisher's exact test, P:0.1540).
In summary, comparison of MFD for each fascicle and the whole population revealed: no
relationship between fascicle size and MFD for the whole population. We also compared
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the MFD between each fascicle and found no correlation between fascicle size and its
corresponding mean MFD in either control or pathological sural nerves (data not shown).
Accordingly, it is impossible to predict which fascicle may have a MFD that can represent
the whole population reliably before all the fascicles are quantitated in both control and
pathological sural nerves.
4.2.2 SYSTEMATIC SAMPLING
From table 4.2-l to 4.2-20 (pp84-93), it is evident that not all systematic samples (from
every 10û to every 2"d field) yield a MFD similar to that of sampling the whole nerve. A
sample will have a different MFD from that of the whole nerve if either the mean value or
the frequency distribution of MFD is different from that of the whole population. Table
4.2-22 (see p97)shows the biggest systematic sample in which MFD differs from the whole
population in mean value andlor spatial distribution with levels of significance set at P<0.05
and P10.2 respectively. With significance of P value set at 0.05, only the every 8ú field
sample of nerve No.20 (p93) has a MFD that is significantly different from the population.
With significance of P value set at 0.2, the systematic sampling method in 1 control and 5
pathological nerves results in a MFD different from that of the whole nerve. The biggest
sample is the every 6ft field in nerve No.2 (1176MFs, 0.l91lmm2TFA of I6.77Yo TTFA)
and No.7 (117lMFs, 0.3l24mm2TFA of l7.o8o/o TTFA). These results imply that
systematic sampling every 5ú field or more will produce a MFD that is probably reliably
representative of the whole nerve. In other words, it is necessary to count at least 20Yo of
the TTFA in order to determine a MFD which is representative of the whole population in
either control or pathological sural nerves.
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4.3 COMPARISON OF FIBRE DIAMETER (Dt) Af{D AXONAL
DIAMETER (DA) OBTAINED BY FASCICLE AND SYSTEMATIC
SAMPLING METHODS TO THAT OBTAINED BY \ryHOLE NERVE
SAMPLING
The mean values and standard deviations of Ds and Da of each sample, and the
comparisons with the whole population for each nerye are displayed in table 4.3-l to table
4.3-20 (see pp98-107), corresponding to nerves No. I to 20. If either the mean value of Ds
or Da or the spatial and frequency distributions of fibre size of a sample differ from that of
the whole nerve, then this sample is not representative of the whole nerve fibre population.
4.3.1 FASCICLE SAMPLING
There is a gteat variation of fibre size among fascicles within the sural nerves in both control
and pathological groups. Table 4.3-21(see p108) shows the percentage of the number of
fascicles in which the fibre size is significantly different from that of the whole population in
each nerve. There were 8 fascicles (57.|yo,8/14) in the two control nerves and 90 (53.6yo,
90/168) in the eighteen pathological nerves in which the mean diameter and distribution of
fibres was significantly different to the whole population. The findings were similar in the
control and pathological groups (Chi-square test, P:0.9185; Fisher's exact test, P:l.0000).
Accordingly, in both control and pathological nerves, no regular pattern was found to
indicate which fascicle contains fibres which reliably represent the fibre size of the whole
population.
4.3.2 SYSTEMÄ.TIC SAMPLING
Table 4.3-22 (see pl09) shows the largest systematic samples in which fibre diameter and/or
axonal diameter are different to the whole population of each nerve. With a level of
significance set at P < 0.05, there are seven nerves (1 control and 6 pathological nerves) in
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which systematic samples of fibre size are significantly different to the whole nerve. For
example, in nerve No.ll, even systematically sampling every 3'd field, which included
1,80lMFs with a O.3945m1rf transverse fascicular area (33.20Yo of TTFA), was not
representative of the whole nerve (see p89 and 103). Similarly in nerve No.2 (control
nerve), sampling every 2nd field, which included 3,293 MFs and 0.5660mm2 fascicular area
(49.65% of TTFA), produced a different mean fibre size and spatial distribution to the
whole nerve with a level of significance set at P<0.2 (see p84 and 98).
To test the hypothesis that data from larger samples can represent the whole population
more accurately, evolution of P-values of fibre diameter was used as a function of the
sample size (expressed as TTFA%) in figure 4.3-1 (see pp110-113). When sample size
increases from about l|Yo up to 50o/o, P-value does not increase simultaneously. In the
same way, it was also found that the precision with which axonal diameter can be estimated
from a systematic sample does not increase with sample size increasing from 10% to 5OYo of
total fascicular area.
Based on these results, it is necessary to count and measure MFs in more than half of the
total fascicular area in order to obtain a reliable representation offibre size
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Table 4.1-l: General description of 20 sural nerves




























































































































































































































Average ofPathol. 9.33 5018 1.4435 37 6.78 4.67
Control: control group
Pathol. : pathological group
NF: number of fascicle per sural nerve
TNMF: total number of myelinated fibres per sural nerve
TTFA: total transverse fascicular area per sural nerve (rn*')
mMFD: mean of myelinated fibre density (number of MFs/mm2)
MFDSD: standard deviation of myelinated fibre density
mDs: mean of fibre diameter (¡.rm)
DsSD: I standard deviation of fibre diameter
mDa: mean of axonal diameter
DaSD:1 standard deviation of axonal diameter
Note: For two control and 15 pathological nerves, the mean*SD values for fibre diameter and
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Figure 4.1-l: Distribution of myelinated fibre density in nerves No.1 to
6, expressed as number of MFs/measuring frame. The number of
myelinated fibres per measuring frame is displayed on the abscissa, and




























































































Number of myelinated fibres per measuring frame
Figure 4,1-l: Distribution of myelinated fibre density in nerves No.7 to 12,
expressed as number of MFs/measuring frame. The number of myelinated
fibres per measuring frame is displayed on the abscissa, and the number of







































































































Number of myelinated fibres per measuring frame
Figure 4.1-l: Distribution of myelinated fibre density in nerves No.13 to 18,
expressed as number of MFs/measuring frame. The number of myelinated
fibres per measuring frame is displayed on the abscissa, and the number of

















Number of myelinated fibres per measuring frame
Figure 4.I-l: Distribution of myelinated fibre density nerves No.19 and
20, expressed as number of MFs/measuring frame. The number of
myelinated fibres per measuling frame is displayed on the abscissa, and the
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Figure 4.1-2: Histograms of fibre diameter, expressed as a percentage
of the total fibre count for nerves No.1 to 6. Fibre diameter is displayed
on the abscissa, and the percentage of the total myelinated fibre count is
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Figure 4.1-2: Histograms of fibre diameter, expressed as a percentage
of the total fibre count for nerves No.7 to 12. Fibre diameter is
displayed on the abscissa, and the percentage of the total myelinated
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Figure 4.1-2: Histograms of fibre diameter, expressed as a percentage
of the total fibre count for nerves No.13 to 18. Fibre diameter is
displayed on the abscissa, and the percentage of the total myelinated
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Figure 4.1-2: Histograms of fibre diameter, expressed as a percentage
of the total fibre count for nerves No.19 and 20. Fibre diameter is
displayed on the abscissa, and the percentage of the total myelinated
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Axonal diameter (micron)
Figure 4.1-3: Histograms of axonal diameter, expressed as a
percentage of the total fibre count for nerves No.l to 6. Axonal
diameter is displayed on the abscissa, and the percentage of the total
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Figure 4.1-3: Histograms of axonal diameter, expressed as a
percentage of the total fibre count for nerves No.7 to 12. Axonal
diameter is displayed on the abscissa, and the percentage of the total
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Figure 4.1-3: Histograms of axonal diameter, expressed as a
percentage of the total fibre count for nerves No.13 to 18. Axonal
diameter is displayed on the abscissa, and the percentage of the total
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Figure 4.1-3: Histograms of axonal diameter, expressed as a
percentage of the total fibre count for nerves No.19 and2O. Axonal
diameter is displayed on the abscissa, and the percentage of the total














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Abbreviations for Table 4.2-l to 4.2-20 see next page
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Abbreviations for Table 4.2-l to 4.2-20
* The MFD of this sample significantly differed from that of the whole nerve in mean value and/or
spatial distribution at the level of significance set at P<0.05.
Bold data: The P values are less than 0.05.
Italic: The biggest systematic sample of which the MFD is different from that of the whole nerve in
mean value and/or in spatial distribution with cut-offof P value set at 0.2.
every nth: every nth field sample
nth Fasci.: nth fascicle sample
NMF: number of myelinated fibres
TFA: transverse fascicular area
TTFA%: TFA/TTFA%
mMFD: mean of MFD
MFDSD: standard deviation of MFD
Wilcox.: Wilcoxon Rank-Sum test evaluates the mean values.
K-S: Kolmogorov-Smirnov test evaluates the shapes of frequency distributions.
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Figure 4.2-I: Fascicle diameter (open circle) and fascicle area (filled circle, mm2) are
plotted against the mean MFD in 6 nerves (No.l to 6). There is no relationship
between fascicle size and mean MFD for either control (No.l and 2) or pathological
nerves (No.3-6). The mean MFD is displayed on the abscissa, and the fascicle
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Table 4.2-21'. Comparison of myelinated fibre density of fascicles with the
whole myelinated nerve fibre population. Values are percentage of the number
of fascicles in which the MFD was significantly different from that of the whole
nerve. Mean values were compared using Wilcoxon Rank-Sum test. The
Shapes of the frequency distributions were compared using Kolmogorov-
Smirnov goodness of fit test. Differences were considered significant when
P<0.05.
of the number of fascicles




































































































Pathol. : pathological group
fcl: frequency distribution
( ): ratio of number of fascicles different from the total number fascicles
constituting the whole nerve
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Table 4.2-22: The largest systematic sample in which the MFD differed from that of the
whole nerye in mean value and/or frequency distribution summarized from table 4.2-l-20























































wery 7th 0.1764 14.85 867










Pathol. : pathological group
TFA: transverse fascicular area (mm2¡
%TTFA: TFA/TTFAxL}}Yo
NMF: the number of MFs in this samPle
every nth: every nth field sample
-: The MFDs derived from the different systematic sample sizes were not significantly different
from the MFD for the whole myelinated fibre population at the set P values.
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Table 4.Tl




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SamnleField mT)s l)sSl-) Prcfiabilitv mDa DaSD Prcfiabiliw
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Samnle Field mT)s I)sSl) Probabiliw mDa DaSD Prchahilitv
total 6.51 3.60 Wilcox. K-S 4.66 2.63 Wlcox. K-S
lst Fasci.* 6.17 2.97 0.2089 0.2071 4.20 1.85 0.0003 0.0005
2nd Fasci.* 6.03 3.20 0.0005 0.0028 4.18 2.14 0.0001 0.0006
3rdFasci.* 6.71 4.12 0.9354 0.1205 4.99 3.27 0.1820 0.0185
4th Fasci.x 6.48 3.01 0.1846 0.0230 4.38 2.05 0.2888 0.1976
5th Fasci.* 7.58 492 0.0053 0.0159 5.69 3.98 0.0001 0.0012
6thFasci.* 7.09 4,71 0.2705 0.0051 5.34 3.79 0.0052 0.0009
TthFasci. 6.84 3.76 0.5031 0.8492 4.88 2.76 0.6353 0.5920
8th Fasci. 6.31 3.16 0.7203 0.2836 4.46 2.18 0.7948 0.5661
9th Fasci. 6.41 3.02 0.6780 0.6787 4.40 1.79 0.8326 0.4269
lOthFasci.* 6.67 3.U 0.1943 0.3727 4.87 2.61 0.0202 0.0225
llthFasci.* 6.16 2.92 0.1779 0.0771 4.41 1.88 0.524 0.0211
l2thFasci.* 6.82 3.30 0.0189 0.0624 4.76 2.14 0.0530 0.0544
øtery 2nd 6.46 3.58 0.5653 0.9850 4.63 2.61 0.4608 0.8997
wery 3rd 6.51 3.59 0.9317 0.9636 4.65 2.60 0.7397 0.9368
wery 4th 6.45 3.57 05282 0.9138 4.61 2.59 0.4377 0.9292
wery 5th 6.63 3.69 0.2124 0.4745 4.77 2.74 0.2167 0.748I
wery 6th 6.51 3.58 0.9231 0.9592 4.67 2.62 0.9547 0.9407
every 7th 6.53 3.61 0.7378 0.9318 4.67 2.66 0.8&7 0.9827
wery 8th 6.51 3.61 0.9793 0.9553 4& 2.61 0.7139 0.9760
every 9th 6.60 3.78 0 7855 0.9855 4.74 2.84 0.9501 0.9531
etterttl}th 6.40 3.46 0.7125 0.6194 4.60 2.51 0.6228 0.8208
Table 4.3-16




























































































































































































































































































































































































































































































































































































































































































































































































































































































































Abbreviations for Table 4.3-I to 4.3-20 see next page
r0'7
Abbreviations for Table 4.3-l to 4'3-20
every nth: every nth field samPle
nth Fasci.: nth fascicle samPle
mDs: mean of myelinated fibre diameter
DsSD: standard deviation of Ds
mDa: mean of axonal diameter
DaSD: standard deviation of Da
Wilcox.: Wilcoxon Rank-Sum test evaluates the mean values
K-S: Kolmogorov-Smirnov goodness of fit test evaluates the shapes of frequency distributions
Table 4.3-2I.. Comparison of myelinated fibre size (Ds and Da) in fascicles with the whole
nerve fibre population. Values are percentage of the number of fascicles in which the fibre
size was significantly different from that of the whole nerve. Mean values were compared
using Wilcoxon Rank-Sum test. The Shapes of the frequency distributions were compared
using Kolmogorov-smirnov goodness of fit test.
Level of signrficance set at P<0.0500 Percentaqe of the Number of Fascicles
Parameter Fibre Diameter Axonal Diameter Total of







57 .t , 57.r










































































































































































Abbreviations for lable 4.3-21
Control: control nerve
Pathol: pathological nerve
spatial dis. : spatial distribution
total of Ds and Da: A sample is thought to have a significantly different fibre size compared to
the whole population if its Ds or Da is different from the whole population.
108
Table 4.3-22. The largest systematic sample rn whch the fibre size
is different from that of the whole nerye





















































every 9th 0.2597 11.50 582










































































Key words for table 4.3-22
Control: control group
Pathol. : pathological group
TFA: transverse fascicular area (mm2)
%TTFA: TFAJTTFAxI00%
NMF: the number of MFs rn thrs sample
every nth: every nth field sample
-: There is no systematic sample (from every l0ù to every 2"d field sample) of which the fibre size
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Figure 4.3-l: P-value of Ds plotted against systematic sample size (nerve No.l and 6).
Wilcoxon Rank-Sum test (open circle) and Kolmogorov-Smirnov goodness of fit test (filled
circle) are used to examine mean value, and frequency and spatial distribution respectively. P




















































Figure 4.3-l: P-value of Ds plotted against systematic sample size (nerve No.7 to 12).
Wilcoxon Rank-Sum test (open circle) and Kolmogorov-Smirnov goodness of fit test (filled
circle) are used to examine mean value, and frequency and spatial distribution respectively. P
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Figure 4.3-l: P-value of Ds plotted against systematic sample size (nerve No.13 to 18).
'Wilcoxon Rank-Sum test (open circle) and Kolmogorov-Smirnov goodness of fit test (filled
circle) are used to examine mean value, and frequency and spatial distribution respectively. P












Figure 4.3-L: P-value of Ds plotted against systematic sample size (nerve No.19 and 20).
'Wilcoxon Rank-Sum test (open circle) and Kolmogorov-Smirnov goodness of fit test (filled
circle) are used to examine mean value, and frequency and spatial distribution respectively. P
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The sural nerve is the most common peripheral nerve studied in humans. Most of the
morphometric data about sural nerve has been obtained using various sampling methods.
However, there is no clear consensus in the literature as to which sampling method is most
accurate.
The th¡ee coÍrmonest sampling methods used in previous quantitative studies are: i) fascicle
sampling, ii) random sampling of the fascicular area in the whole nerve and iii) systematic
sampling of the fascicular area of every fascicle in the whole nerve @yck et ql. 1984, Dyck
et al. 1986a" Dyck et al. 1986b, Mayhew et al. 1981, Sa.xod et al. 1985, Tang and
Ebbesson 1972, Thomas et al. 1993, Torch et al. 1989a). Fascicle sampling is performed
on tissue obtained by fascicular biopsy. Some researchers prefer fascicular biopsy to whole
nerve biopsy in order to minimize resultant sensory deficits (Dyck and Lofgren 1966, Dyck
et al. 1993, Thomas 1970) and avoid the risk of 'trophic' ulceration (Llewelyn et al. l99I).
Systematic sampling is recommended when the whole nerve is available because it can
provide information about the spatial distribution of nerve fibres (Dyck et al. 1984, Dyck et
al. I986a, Dyck et al. 1986b) and it is more accurate than random sampling (Mayhew et al.
1981). Sample size may be based on either the number of myelinated fibres or the
transverse fascicular area. In most previous studies, hundreds to one or two thousand MFs
or the fibres in about 0.1mm2 fascicular area were measured (Behse 1990, Dyck et al.
1986a, Dyck et al. I986b, Gabreëls-Festen et al. 1992, Gabreels-Festen et al. 1995, Jacobs
and Love 1985, Llewelyn et al. 1991, Schellens et al. 1993). However there is no
consensus as to how many myelinated fibres need to be measured in order to produce a
statistically valid representation of the whole myelinated fibre population in a sural nerve. In
morphometric studies of myelinated fibres in sural nerves, Ferriere et al. (1985) and
Sch¡öder et al. (1978) found that the thickness of the myelin sheath was linearly related to
the axonal diameter for all the myelinated fibres. But Friede and Beuche (1985) found that
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type-III and type-Il fibres had dif[erent relationships between the thickness of myelin sheath
and axonal diameter, and that the separation of the two populations was more distinct if
more MFs were measured. This suggests that a small sample size may introduce bias, and
that accurate estimation of the myelinated fibres in sural nerve needs a suitable sample size.
The characteristics of individual myelinated fibres vary greatly, and there is a non-uniform
distribution of myelinated fibres in peripheral nerves (Dyck et al. 1984, Dyck et al. I986a,
Dyck et al 1986b, Saxod et al. 1985, Torch et al. I989a). In pathological nerves, loss of
myelinated fibres may be focal, multifocal or diffilse, and the changes of spatial pattern of
MFs may be an indicator of the underlying pathological mechanism @yck et ql. 1984, Dyck
et al. 1986a, Dyck et al. I986b, Dyck et al. 1993). Therefore when assessing the accuracy
of sampling methods, the spatial distributions of myelinated fibre density and fibre size
should be compared as well as the mêan values.
5.1 FASCICLE SAMPLING METHOD
5.1.1 TRANSVERSE FASCICULAR AREA, MYELINATED FIBRE DENSITY AND
MYELINATED T'IBRE DENSITY FRE QUENCY DISTRIBUTION
The fascicle size varies widely in peripheral neryes (Behse 1990, Jacobs and Love 1985,
O'sullivan and Swallow, 1968, Saxod et al. 1985, Swallow 1966, Torch et al. 1989a,
Walsh L97l), and the number of MFs within each fascicle varies according to its fascicular
area (Swallow 1966, O'sullivan and Swallow 1968, Saxod et al. 1985). In control human
sural nerves, the size of individual fascicles varies from less than 100pm in diameter to
O.46mm2 in transverse area (Jacobs and Love 1985, O'sullivan and Swallow 1968, Walsh
I97I). The small number of myelinated fibres in small fascicles less then 100pm can be
ignored in quantitative studies (O'sullivan and Swallow et al. 1968, Swallow 1966), and
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were excluded from quantitation in this study, There were a total of l4 fascicles in the two
control sural nerves in this study. The fascicular area of individual fascicles varied from
0.0392mm2 to 0.2940mm2, similar to that of O'sullivan and Swallow (1968) and Walsh
(1971), but greater than that of Jacobs and Love (1985). The difference may be due to
different methods of tissue preparation and counting. Dyck et al. (1981b) proved that
hypersosmolar fixatives caused severe shrinkage of fascicular area. In this study, the nerve
tissues were fixed in isosmotic fixatives, dehydrated in graded concentrations of ethanol and
propylene oxide, and embedded in resin. We did not compare the fascicular area in plastic
and cryostat sections. In accord with previous studies, the estimated shrinkage of fascicular
area in our series was about 10% (Behse 1990, Dyck et al. I98lb). In our study, the
transverse fascicular area of each fascicle was obtained by additions of the areas of all the
measuring frames in the fascicle. Previous studies have obtained TFA by drawing the
contour of the fascicle under loWer magnification, and cutting out and weighing the
resultant tracing (Behse 1990), or tracing the outer edges of the endoneurium with a cursor,
and calculating the fascicular area with a digitizer (Dyck et al. 1986a). Uniform
measurements of fibre diameter, axonal diameter and fascicular area at the same final
magnification would allow an easier comparison of data obtained in different laboratories.
The mean myelinated fibre density (ltÆD) varies considerably among fascicles in peripheral
nerves. In one control anterior tibial nerve, Swallow (1966) found that mean MFD varied
from 5900 to 9088/mm' in 5 fascicles. In control sural nerves, Behse (1990) found the
myelinated fibre density of fascicles deviated from the mean fibre density of the nerve by
between -21% to +37Yo. In the two control nerves in this study, the mean MFD of each
fascicle varied from 4045 to 5763lmnf in nerve No.1, and from 5130 to 63861mm2 in nerve
No.2. The deviation of MFD of each fascicle from the mean MFD of the whole nerve
ranged from - 1 8% ¡ç +l7Yo in nerve No. 1 and from - I lYo to l}Yo in nerve No.2,
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In studies of superficial peroneal nerves, Saxod et al. (1985) concluded that the myelinated
fibre density is related to fascicle diameter. We did not find any correlation between the
mean MFD of each fascicle and the fascicle size (fascicular area or fascicle diameter) in
either the control or pathological sural nerves (Figure 4.2-l). Our reinterpretation of the
data presented by Saxod et al. (1985) shows that the number of constituent myelinated
fibres was positively linearly related to the fascicular area of each fascicle within control
superficial peroneal nerves contrary to the conclusion made by the authors. Similar results
were obtained in the control sural nerves in this study. Accordingly, it is impossible to
predict which fascicle may have a myelinated fibre density comparable to that of the whole
nerve before quantifying all the fascicles
The comparisons of frequency diótribution of myelinated fibres between the whole
population and fascicle samples or between fascicle samples revealed that the frequency
distributions were different between fascicles in control sural nerve, and there was no
relationship between fascicle size and its MF frequency distribution to that of the whole
nerye.
The mean fibre density and its frequency distribution varied considerably among fascicles in
our control sural nerves, and the variation was not related to the fascicle size. Therefore, it
is impossible to ascertain which fascicle is a statistically valid sample to represent the
myelinated fibre density and the fibre density spatial distribution of the whole population in
control sural nerves.
In neurological disorders and neuropathies, the pathological changes affecting fascicles may
be patchy. For example, in diabetic distal polyneuropathy, the pathological changes may be
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more severe in some fascicles, while others are relatively exempt from damage (Dyck et al.
1986a, 1986b). The mechanism of patchy damage is unclear in most peripheral nerve
diseases. For this. reason it is necessary to study all the fascicles when investigating the
morphological and morphometric changes in peripheral nerves. In our material the biggest
variance of fascicular mean MFD was found in nerve No.7, with the highest mean MFD of
42l5lmm2 in the th fascicle and the lowest of 2084/mm2 in the 6ù fascicle (see p87). The
highest mean MFD was 202Yo of the lowest. We were unable to establish any criteria by
which a single fascicle, representative of the mean MFD and the MFD frequency
distribution of the whole nerve, could be selected in either the control or pathological
nerves. Thomas et al- (1993) showed that there was less variation in fibre densities than the
number of fibres in fascicular biopsies and concluded that the mean MFD was the
measurement of choice. However we found that MFD varied considerably in agreement
with previous studies (Swallow 1966, Saxod et al. 1985). Thus the myelinated fibre density
derived from one fascicle or part of a fascicle/s is not an accurate representation of the
whole MF population.
5.1.2 MYELINATED FIBRE SIZE (FIBRE AND AXONAL DIAMETER)
The spatial pattern of MFs in the fascicles of peripheral nerve is heterogeneous not only in
fibre number but also in fibre size (Dyck et al. 1984, Dyck et al. L986a, Dyck et al. I986b,
Torch et al. 1989a). In previous studies only the fibre diameter \Ã/as assessed when
investigating the mean value of fibre size and size spatial distribution (Dyck et al. 1984,
Dyck et al. 1986a, Dyck et al. 1986b, Mayhew et al. 1987, Torch et al. 1989a). Although
the thickness of the myelin sheath in normal peripheral nerves may be positively related to
the total fibre size or axonal size on cross section @ehse 1990, Dyck et all9'Tla,Dycket
al. L97Ic, Friede 1972,Fnede and Samorajski 1967, Ferriere et al. 1985, Jacobs and Love
1985, King 1994, Schröder et al. 1978, Thomas et al. 1993), that does not mean that fibres,
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which have the same fibre diameter or axonal diameter on cross section, always have the
same thickness of myelin sheath even in normal peripheral nerves. As part of the present
study, MFs were divided into 20 subgroups based on axonal diameter (Da): DaSlprm,
1<DaS2pm and so on. Analysis of the histograms of the thickness of myelin sheath showed
that every subgroup had a spectrum of the thickness of myelin sheath and a spectrum of g-
ratio in both control and pathological nerves. In pathological nerves, an atrophic axon with
a thick myelin sheath may have the same total fibre diameter as a remyelinating fibre which
has a relatively normal a¡<on and disproportionately thin myelin. A comprehensive
representation of fibre size should include accurate representations of both fibre diameter
and axonal diameter in mean values and spatial distributions.
Fibre size and its spatial distribution also varied considerately among fascicles within the
nerve both in the control and pathcilogical groups, and these variations did not relate to
fascicle size and the mean MFD of individual fascicles. 57 .I% of the fascicles in 2 control
nerves, and 53.6% (16.7% to 88.9%) of the fascicles in 18 pathological nerves had
significantly different fibre size (fibre diameter and./or axonal diameter) mean values and/or
size spatial distribution to the whole MF populations. Both the fibre size and its spatial
distribution varied considerably, and no regular pattern was found to predict this variation.
Quantifying the features of individual MFs in only one or a few fascicles (Dyck et al. l97la,
Dyck et al.l986a. Dyck et al. L986b, Engelstad et al. 1997, Llewelyn et al. 1997, Thomas
et ql. I977, Thomas et al. 1987, Webster et ol. 1967) may produce biased results.
Thus it is impossible to determine which fascicle to measure to obtain an accurate
representation of mean fibre size and spatial distribution of the whole MF population.
Quantification of all the constituent fascicles is necessary in morphometric studies of sural
nerve to ensure accurate results. Pollock et al. (1983) studied a series of patients who had
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undergone fascicular or whole sural nerve biopsies, and found that the resultant neurological
deficits were similar in the two groups after 5 years. Accordingly, it is probably better to
perform whole sural nerve biopsies because quantitative studies will be more accurate and
the procedure is surgically simpler than fascicular biopsy
5.2 SYSTEMATIC SAMPLING METHODS
Systematic sampling methods include systematic sampling of the fascicles (Dyck et al.
1986b) and systematic sampling of the fascicular area in every fascicle of the nerve (Dyck et
al. 1984, Dyck et al. 19864 Saxod et al. 1985, Tang and Ebbesson 1972, Torch et al.
1989a).ì In this study we assessed the accuracy of systematic sampling of the fascicular area
in every fascicle of the nerve.
An important advantage of this systematic sampling method is that it can be used to
recognize the spatial distribution of'myelinated fibres (Dyck et al. 1984, Dyck et al. I986a,
Dyck et al. 1986b, Torch et al. 1989a). Loss of fibres is one of the most common
pathological phenomena in peripheral neuropathies. The loss of MFs may be focal,
multifocal, or diffi¡se @yck et al. 1993). By comparing the density and size of myelinated
fibres using measuring frames, focal, multifocal and diffi;se changes of myelinated fibre
density and fibre size can be recognized (Dyck et al. 1993). The spatial pattern of nerve
fibre abnormality may be useful in diagnostic evaluation (Dyck et al. 1984). For example
ischaemic neuropathies due to focal pathological change of small arteries usually show
patchy loss of myelinated fibres that varies from fascicle to fascicle (Dyck et al. 1984).
Dyck and co-workers @yck et al. 1986b, Sugimura and Dyck 1982) found patchy
multifocal fibre loss in diabetic neuropathies. Since capillary basement membranes are
thickened (Aagenaes and Moe 1961, Siperstein ef al. 1966, Siperstein et al. 1968), with
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capillary thrombosis (Timperley et al. 1976, Williams et al. 1980) and in the absence of any
direct affect of hyperglycemia on nerve (Service et al. 1985), they proposed that diabetic
neuropathies v/ere caused by ischaemia due to the microvascular pathological abnormality
@y"k et al. 1986a, 1986b).
In order to determine the spatial distribution of MFs, it is necessary to select a suitable size
measuring frame. If the measuring frame is too large, multiple fields of a fascicle cannot be
surveyed and variability of density within fascicles cannot be estimated. If too small, the
measuring frame would contain few or no fibres. Dyck et al. (1984, 1986a, 1986b)
estimated the spatial distribution of MFs at a final magnification of approximately x2000 in
human and animal peripheral nerves. In human superficial peroneal nerves, a final
magnification of x1130 was used to estimate fibre density spatial distribution (Saxod et al.
1985), and a magnification of x}l}Cjwas employed to determine the fibre size distribution
(Torch et al. 1989a). Initially we used a magnification of x2371to determine fibre size and
frequency distribution. But some scattered small thin myelinated fibres were missed by the
image analysis system probably because the myelin sheath was too thin and the colour too
pale. On the other hand, some myelinated fibres, especially clusters of regenerating fibres
with closely touching fibres were misinterpreted by the image analysis system as distorted
larger fibre(s). When the final magnification was changed to x3018 (x100 objective), these
problems were minimized. At the final magnification of x3018, the area of each measuring
frame is 2450pm2. Within each measuring frame the number of MFs ranged from2 to 26 in
the two control sural nerves, and from 0 to 28 in the eighteen pathological nerves. For
morphometric studies of diseased sural nerves, the final magnification of x3000 may be
more suitable than that of x2000 in determining the number, shape, size, and spatial
distribution of myelinated fibres
122
Although systematic sampling methods have been used in previous studies of peripheral
nerye @yck et al- 198{ Dyck et al. 1986a, Dyck et al. 1986b, Ebbesson 1963, Ebbesson
1968, Mayhew et al. 1981, Saxod et al. 1985, Tang and Ebbesson 19'72, Torch et al.
1989a), little information is available about their accuracy relative to measurements of MFs
in the whole nerve, especially in human sural nerve. Mayhew et al. (1981) showed that
systematic sampling of the fascicular area was more accurate than random sampling in
quantitating rat tibial nerves. Tang and Ebbesson (1972) found that the MFs in about 50%
of the total fascicular area needed to be counted in both systematic and random sampling
methods to obtain accurate data representative of the total number of MFs in cranial nerves.
Sorod et al. (1985) pointed out that MFD can only be reliably established by counting all
the fibres within a fascicle or a nerve in human superficial peroneal nerves. In rats, Dyck et
al. (198\ used the systematic sampling method to quantitate MFs in every 3'd field in
sciatic, peroneal and tibial nerves in.a study of spatial distribution of MFs. In quantitative
studies of human diabetic neuropathies (with and without vasculitis), Dyck et al. (I986b)
sampled every 12ú field in large fascicles. Torch et al. (1989) found that measurements
performed on up to l}Yo of the total myelinated fibres in control human superficial peroneal
nerve were not an accurate representation of the whole MF population.
To the best of our knowledge, no previous study has assessed the accuracy of fibre density
and fibre size obtained by systematic sampling to that obtained by whole nerve sampling in
human sural nerves.
5.2.L MYELINATED FrBRE DENSTTY (MFD)
The variation of MFD in systematic samples was not as great as that in fascicle samples.
However, there were still some samples in which the MFD differed from that of the whole
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population in both control and pathological nerves. At the level of significance set at
P<0.05, theMFD differed significantly from that of the whole nerve in oniy every 8ú field
sample of one pathological nerve. If P is set at 0.2, l control (50yo, 112) and 5 (27.8yo,
5/18) pathological nerves had systematic samples in which MFD differed from that of the
whole nerve. Even sampling every 6ú field in a control and a pathological nerve Q{o.2 and
7, see pl11) still cannot obtain the MFD that reliably represents the whole myelinated fibre
population. In the control nerves, the variation of MFD between systematic samples
suggested that the spatial distribution of myelinated fibres was non-uniform within fascicles,
confirming the findings of other researchers (Dyck et al. 198{ Dyck et al. 1986a, Dyck et
al. 1986b, Saxod et al. 1985, Torch et al. 1989a). In the pathological nerves, the variation
of MFD in systematic samples may reflect the intrinsic pattern of non-uniform distribution in
normal nerve or may be secondary to the pathologic process. Patchy loss of MFs and
reduction of fibre density were obvious by visual inspection in some pathological nerves.
Severe loss of MFs decreases both fibre density and variation of fibre density within
fascicles. Less severe focal pathological change probably produces an increased variability
of MFD (Dyck et al. I986a). In nerve No.3, showing only mild pathological changes, the
variation of MFD within fascicles ranged from 0 to 28lmeasuring frame, bigger than that in
the two control nerves. Increased focal fibre density may also occur as in clusters of
regenerating nerve fibres.
In normal rat sural nerve it has been reported that large fibres approach a random
distribution, while small fibres tend to be clustered (Dyck et al. 7984). However visual
inspection of our human materials, showed that the distribution of large and small fibres was
heterogeneous within fascicles in both control and pathological sural neryes. The pattern of
spatial distribution of MFs within peripheral neryes has been divided into two groups:
weakly and strongly heterogeneous (Saxod et al. 1985). In our study we did not
124
deliberately select the nerves in which MF spatial distribution was strongly heterogeneous,
but we did exclude nerves with a mean myelinated fibre densþ so low that one measuring
frame contained an average less than 2 myelinated fibres. In previous studies, myelinated
fibre density in whole sural nerve was usually derived from about L}yo of the total
transverse fascicular area (TTFA) or about 0.1mm2 of fascicular atea (Gabreëls-F esten et al.
1992, Gabreëls-Festen et al. L995, Jacobs and Love 1985, Schellens e/ al. 1993, Tohgi et
al. 1977b), Although the fibre densities of most systematic samples in this study were not
significantly different from that of the whole nerye (P<0.05), we found that the myelinated
fibre density of the systematic sample derived from up to l7%o of TTFA or O.3724mnJ
fascicular area (see p97) ditrered from that of the whole population at the level of
significance set at 0.2. This result is consistent with the findings of Saxod et al. (1985) and
Tang and Ebbesson (1972).
Behse (1990) suggests that the numb.er of fibres per nerve is a more reliable parameter than
the fibre density if different methods of tissue preparation and staining are used because the
shrinkage of the endoneurial area and of the fibre size may be different. However in nerve
No.20, sampling every 7ü field produced a fascicular area of o.2l07mnf Q4.7% of TTFA)
and 437 myelinated fibres, while sampling every 8ú field resulted in a fascicular area of
0.1813mm2 (12.7% of TTFA) and 447 myelinated fibres (see p93). The larger fascicular
area sample contained less fibres than the sample of smaller fascicular area because of the
great variation of myelinated fibre spatial distribution. Therefore, myelinated fibre density
derived from systematic sampling the fascicular area in every fascicle of the sural nerve is
relatively comparable to that of sampling the whole nerve, but is still not completely
representative of the whole MF population.
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5.2.2 VI.YELTNATED FrBRE SIZE (FTBRE AND AXONAL DTAMETER)
Torch et al. (1989) proved that measurements performed on up to l0%o of the total
myelinated fibres in superficial peroneal nerves were not representative of the fibre diameter
of the whole population. 'We studied sample sizes varying from l}Yo to 50Yo of the total
fascicular area, roughly corresponding to 10%o to 50o/o of the total number of myelinated
fibres. Our results show that even sampling 50% of the total fascicular area in control sural
nerve still cannot produce fibre or axonal diameters that are representative of values
obtained by whole nerve sampling. This applies to both the mean values and the frequency
distributions of fibre and axonal diameters. This is because the spatial size distribution of
MFs within fascicles is non-uniform in control sural nerve. In pathological nerves, selective
loss of myelinated fibres and clusters of regenerating fibres produce an uneven spatial
distribution of fibre size.
I
It is commonly accepted that the aqcuracy of the representation of samples increases with
increasing sample size, but this was not the case in our study. Similar findings were
reported by Torch et al. (1989). This finding is attributed to the heterogeneous spatial
distribution of fibre size within fascicles. We found that even sampling every 2"d field the P
value was less than Q.2 in control sural nerves. This indicates that the MFs in more than half
of the fascicular area in every fascicle needs to be counted in order to get results
representative of the whole myelinated fibre population in the sural nerve.
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5.3 COMPARISON OF DATA RELATING TO FASCICLE NUMBERS,
TOTAL TRANSVERSE FASCICULAR AREA, TOTAL NUMBER OF
MYELINATED FIBRES, NIYELINATED FIBRE DENSITY AI.ID
FIBRE SIZE WITH THAT REPORTED IN THE LITERATURE
The number of fascicles, total transverse fascicular area, total number of myelinated fibres
and myelinated fibre density in the two control sural neryes and the pathological sural
nerves in this series are similar to those reported in previous studies (Behse et al. 1990,
Jacobs and Love 1985, O'sullivan and Swallow 1968). Comparison of fibre and axonal
diameter in our study with that reported in the literature revealed a slightly greater fibre size
in this series with consequent shift in the histograms of frequency distributions of fibre and
axonal diameter to the right by approximately 2-3¡-rm. Two reasons may account for these
differences. First, the nerve tissues in our study were fixed in isosmolar fixatives and
embedded in resin reducing the shrinkage factor (Dyck et al. 1980). Second, the myelinated
fibre diameter and axonal diameter wére derived from the myelin sheath area combined with
the perimeters of the myelin sheath,,not from the axonal area and the total area of fibre on
cross section. During tissue preparation, shrinkage is unavoidable, but the myelin sheath
area and the perimeter remain relatively constant (Auer et al. L994, Dyck et al. 1980).
5.4 CONTROLS
For each of the twenty sural nerves, the results obtained by sampling were compared to
those obtained by study of the whole nerve. Accordingly, the effects of aging, the type of
pathological process and variation between nerves were not relevant to this study (Behse
1990, Jacobs and Love 1985, Schellens e/ al. 1993, Saxod et al. 1985, Tohgi et al. 1977b,
Thomas et al. 1993, Thomas et al. 1997). Moreover, since the specimen fixation and
embedding methods were identical in all cases, their influence on nervous structures (Behse
1990, Dyck et al. 1981b) also did not affect the results.
l2'7
Conclusions
1. The mean values, frequency distribution and spatial distribution of myelinated fibre
density, fibre diameter and axonal diameter are heterogeneous between fascicles in both
control and pathological sural nerves.
2. There is no relationship between the myelinated fibre density of each fascicle and the
fascicle diameter or area in the sural nerve.
3. Morphometric results from one or part of a fascicle cannot accurately represent the
whole myelinated fibre population in the sural nerve.
4. Systematic sampling of the myelinated fibres in half of the fascicular area of every
fascicle in the sural nerve is not accurately representative of the whole myelinated fibre
population.
5. In morphometric studies of the sural nerve, the accuracy of representation of samples
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Illustrations of Histological Features
{
rl
Figure 1: Upper part shows part of the cross section of a control sural nerve (nerve No.2, toluidine blue
stained, x100). Epineurium (arrow), perineurium (arrowhead), endoneurium (asterisk), blood vessels (double
arrow), adipose (star) and 3 complete fascicles (1st, largest; 2nd, middle; and 7th, smallest) in this picture. On
visual inspection, the spatial distribution of myelinated fibres in each fascicle is heterogeneous. Myelinated
fibre density is 5785/mm2 for the whole nerve, 6386lmmz for the lstfascicle,5130/mm2 for the 2nd fascicle
and 5210/mmz for Jth fascicle(see p84). Lower part shows high magnification (x200) of the 1st fascicle. It is
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Figure 2: Fibre diameter frequency distributions of the whole myelinated fibre population in nerve No.2 and
in the 1't, 2nd and 7ù fascicle (Figure 1). Fibre diameter (micron) is displayed on the abscissa, and the
percentage of the total myelinated fibre count is displayed on the ordinate. Fibre diameter mean values and
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Figure 3: Upper part shows three fascicles (6'h, upper right; 7th lower right; and 8il', left) in nerve No.7
(toluidine blue, x100). Loss of myelinated fibres is uneven within and between fascicles. Myelinated fibre
density is 3006imm2 for the whole nerve, 2084/mm2 for the 6th fascicle, 3llllmm2 for the 7th fascicle and
2590/mmz for 8'r' fascicle (see p87). Lower part shows the fibre diameter (Ds) frequency distribution in the
whole nerve and the three fascicles. Ds is displayed on the abscissa, and percentage of total myelinated fibre
count is displayed on the ordinate. It is obvious that the mean value of Ds and the graphic curve of Ds
frequency distribution of the 6th fascicle are different to those of the whole nerve. The mean value of Ds of
the 7'h fascicle is similar to that of the whole nerve, but Ds frequency distribution is obviously bimodal in the
7'h fascicle and looks like unimodal in the whole nerve. Kolmogorov-Smirnov goodness-of-fit test proved Ds
frequency distributions are significantly different in the whole nerve and the 7th fascicle. The mean value and









































6th Fascicle': Fibre Eriameter



























































8th Fascicle: Ebre Da¡rete¡
nE!l]+SD=6.42+3.2I
rWilcoxon Ra¡rk-Sum: P = 0,61 15
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Figure +' eut^trotogl"al changes in a sural nerve (No. 17, toluidine blue stained, x40O). Disproportionately
thin myelin sheaths for axonal diametel indicative of remyelination (arrow). Fibres showing myelin infolding
are also present (arrowhead).



























































































































































































































































































Module for extracting data from every nth field to form systematic
samples and for calculating fibre diameter, axonal diameter and the
number of myelinated fibres per measuring frame
Sub sample0




Sheets.Add after: =Sheets( " Sheet 1 " )
ActiveSheet.Name - "Every " + varl
v arZ = ActiveS heet.Name
Cells(1, 1).Select
Sheets(" Sheet 1 " ). Select
Columns( " c " ).Find( " 2" ). Select
ActiveCell. Offset(O, - 1 ). Select
Do While ActiveCell <> Empty
Do Until ActiveCell.Value <> ActiveCell.Offset(1, 0) -
Or ActiveCell.Value = Empty
rowl = ActiveCell.Row









counter = counter + ((row2 + 1) - rowl)
Sheets( " Sheet 1 " ).Select
Cells(row2, 2).Select
vll
var3 = ActiveCell.Offset(0, 1)
Do Until ActiveCell.Offset(0, 1) = var3 + varl -
Or ActiveCell.Offset(0, 1) < var3
If ActiveCell.Value = EmptY Then Exit Do
ActiveCell.Offset( 1, 0).Select
Loop












ActiveCell.Offset(O, 1) = "Fascicle"
ActiveCell.Offset(0, 2) = "Field"
ActiveCell.Offset(0, 3) = "Area"
ActiveCell.Offset(0, 4) = "Length"
ActiveCell.Offset(0, 5) = "Breadth"
ActiveCell.Offset(O, 6) = "Perimeter"
ActiveCell.Offset(O, 7) = "Fibre Diameter"
ActiveCell.Offset(0, 8) = "Axon Diameter"
Cells(2, 8).Select
Do Until ActiveCell.Offset(0, -1) = Empty
ActiveCell.Formula = 0.11 * (((0.5 x ActiveCell.Offset(0, -1)) + -





Do Until ActiveCell.Offset(0, -2) = Empty
ActiveCell.Formula = 0.11 * (((0.5 * ActiveCell,Offset(O, -2)) - -




Cells(l, l0).Value = "Case"
Cells(1, 1 1).Value = ActiveCell.Offset(0, -9)
Cells(2, 10).Value = "Fascicles"
Columns( "b ").Find(Empty).Select
varl = ActiveCell.Offset(- 1, 0)
Cells(2, 1l).Value = varl
Cells(1, 12).Value = "Fascicle"
Cells(1, 13).Value = "Field"
Cells(1, l4).Value = "Fibres in Field"
Cells(1, 15).Value = "Myelin in Field"
Cells(2, 3).Select
Do While ActiveCell.Offset(0, -1) <> Empty
field num = 1
myelin = 0
Do While ActiveCell.Value = ActiveCell.Offset(1, 0) -
And ActiveCell.Offset(O, -1) = ActiveCell.Offset(1, -1)
field num = field num + 1




Range(Cells(rownum, 2), Cells(rownum, 3)).Copy
Columns( 1 2).Find(Empty).Select
ActiveSheet.Paste
ActiveCell.Offset(O, 2).Value = field-num
ActiveCell.Offset(O, 3).Value = myelin










"HISTOGRAM([nerve.xls] !C8, [nerve.xls] !RlC11,[nerve.xls] !R1C1O:RZOCIO,
FALSE, FALSE, FALSE, TRUE)''
Stop
Application.ExecuteExcel4Macro String:= -
"HISTOGRAM([nerve.xls]Sheetl !C9, [nerve.xls]Sheetl !R1C1 3,
[nerve.xls]Sheetl !R1C10:R20C10, FALSE, FALSE, FALSE, TRUE)"
Range( " K 1 :L22" ).Select
Charts.Add
ActiveSheet.Name = varl + "(Fibre)"
ActiveChart.ChartWizard Source:=Sheets(var 1 ).Range(" K1'.L22" ), -
Gallery:=xlColumn, Format:= 1, PlotBy:=xlColumns, -
Categorylabels:=1, Serieslabels:=1, Haslegend:=0, Title:="Fibre Diameter"
Sheets( " Sheet 1 ").Select
Range("M 1 :N22").Select
Charts.Add
ActiveSheet.Name = varl + "(Axon)"
ActiveChart. ChartWizard S ource : =Sheets (var 1 ).Range( " M 1 :N22 " ), -
Gallery:=xlColumn, Format:= 1, PlotBy:=xlColumns, -




Intra- and inter- observer variation: The following table and histograms illustrate
the results obtained by the author from measurements on two separate occasions of the
myelinated fibre content within the first fascicle of nerve No.2. A further series of
measurements were conducted by another observer (3rd measurement) demonstrating
essentially the same result, and therefore low inter-observer variability. Comparisons
between the mean fibre density (MFD), the numbers of MF in each measuring frame, and
fibre and axonal diameter were undertaken using the Wilcoxon Rank-Sum test for the mean
sample values and the Kolmogorov-Smirnov goodness-of-fit test for the frequency
distribution of fibres. Three way analysis of variance (ANOVA) compared the MFD, Ds
and Da of the first and second measurements by the author and the third measurement by
another observer. There is no significant difference among the results of the three
measurements.
Table: TFA, NMF, MFD, Ds and Da for the 1st fascicle of nerve No.2. Two consecutive
measurements by the author and a third by another observer with comparisons of inter and
intra observer variability are shown.
Data TFA(mm2) NMF MFD(/mm2) Ds(pm) Da(pm)
lst measurement 03112 1987
2nd measurement 0.3087 1923
xW ilcoxon Rank-Sum test
xKolmogorov-Smirnov goodness-of-fit test




























TFA: transverse fascicular area
NMF: number of myelinated fibres
MFD: myelinated fibre density
Ds: fibre diameter
Da: axonal diameter
x compared to the results of the 1st measurement
xx another observer
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Figure: Histograms show frequency distributions of Ds and Da. Ds and Da are displayed on











































































































6 12 "21 weeks" shouldbe"15-21weeks"
10 2 "conventiona" should be "convention"
11 "daimeter" should be "diameter"
15 4 "arteries veins" should be "arteries and veins"
15 20 "in to" should be "into"
27 22 "at I5-L6 weeks" should be"at l5-2lweeks
31 2 "lower peakupper peak" should be "lower peak upper peak"
37 14 "In the development" should be "In development"
41 10 "maÍry" should be "many pixels."
The line between line 12 and 13 should be between line 13 and 14
51 "following legionella pneumonia" should be "sensorimotor neuropathy post
Legionella pneumonia"
53 6 "23o/odemyel." should be"23Yo demyel."
57 10 "On" should be "One"
98 11 "enery 2nd' shouldbe"every 2nû'
130 24 "cell" should be "Ce11"
133 13 "merve" should be "nerve"
30 "dimentions" should be "dimensions"
136 18 "involove" should be "involve"
139 15 "myelin-axxociated"shouldbe"myelin-associated"
r4l Thomas references should been placed after Taniuchi et al. in page 140
'Wilcoxon Rank-Sum test compares the medians, not mean values, between samples.
